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ABSTRACT 
Cloning, Heterologous Expression in Yeast, and Biochemical Characterization of Recombinant 
Putative Glucosyltransferase Clones 9 and 11 from Grapefruit (Citrus paradisi)  
by 
Anye Wamucho 
Flavonoids are plant secondary metabolites that play diverse roles in plants and human health. 
These compounds in most part exist in the glucosylated form. Grapefruit accumulates high levels 
of glucosylated flavonoids. Plant secondary product glucosyltransferases (GTs) catalyze the 
glucosylation reaction, but due to low homology at both the nucleotide and amino acid sequence 
level of different GTs, it is not possible to ascribe function based on sequence only. The 
hypotheses that PGT clones 9 and 11 are plant secondary product GTs and are biochemically 
regulated were tested. PGT 9 has been cloned into Pichia pastoris using the pPICZA and 
pPICZAα vectors, expressed, enriched, and screened for GT activity with a variety of phenolic 
substrates. Initial screens show catechol, gentisic acid, vanillin, and p-hydroxylphenylacetic acid 
as potential substrates for the PGT 9 protein. PGT 11 has been successfully cloned into pPICZA 
for transformation into yeast, expression, and subsequent characterization. 
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CHAPTER 1 
INTRODUCTION 
Plant Secondary Metabolites 
Plants produce a myriad of organic chemical compounds that play essential roles such as 
pigmentation, pollination, seed dispersal, flavor (odor and taste), and interactions with other 
organisms such as insects, animals, and other plants (Bennet and Wallsgrove 1994 and ref. 
therein; Zhao et al. 2005 and ref. therein; Martens et al. 2010 and ref. therein; Kennedy and 
Wightman 2011). In the presence of stress, new compounds or modified versions of the pre-
existing compounds are produced which help the plants fight off abiotic and biotic stresses such 
as high UV exposure and infections amongst others (Li et al. 1993; Cohen et al. 2001 and ref. 
therein; Cushnie et al. 2005 ). 
Some of the organic chemical compounds produced in plants are classified as secondary 
metabolites. As opposed to primary metabolites being common to almost all plants, only a subset 
of secondary metabolite genes are found in some plants and as such can be used as taxonomic 
markers (Bennet and Wallgroves 1994 and ref. therein; Pichersky and Gang 2000 and ref. 
therein). For example, grapefruit and blonde orange do not accumulate anthocyanin but blood 
oranges do and it is a close relative to both (Owens and McIntosh 2009 and ref. therein). New 
secondary metabolites continue to be unraveled. This may be due to evolution of new genes that 
produce these new secondary metabolites (Pichersky and Gang 2000). Like all living organisms, 
plants are faced with several challenges that hinder their growth and survival. Over the years, 
plants have coped with such challenges by developing a myriad of defense mechanisms. Pests, 
infections, and extreme environmental conditions not suitable for plant growth and survival are 
amongst the challenges faced by plants. Herbivory is also one of the factors that drastically 
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affects plants as insects and animals tend to feed on them. This may explain the need for new 
protective compounds in order for plants to survive these challenges. 
There exist several different types of plant secondary metabolites with different functions 
as earlier mentioned. Three main classes of secondary metabolites are: terpenoids, alkaloids, and 
phenolic compounds (Zwenger and Basu 2008 and ref. therein). The largest group of plant 
secondary metabolites are the terpenoids with ~30,000 compounds followed by the alkaloids 
with ~ 12,000 compounds (Martens et al. 2010 and ref. therein). The third largest group 
constitute phenolics of which there are well over 10,000 compounds (Martens et al. 2010 and ref. 
therein).  
Due to the high content of secondary metabolites in plants, research on the effect of these 
molecules on human health has increasingly become popular as plants constitute a major part of 
human and animal diet.  Several findings suggest that these compounds have several beneficial 
roles to humans. These compounds have been shown to be treatments for wounds, bacterial 
infections, cancer risk, coronary heart disease, and strokes among others (Cook and Sammons 
1996 and ref. therein; Hollman et al. 1999 and ref. therein; Sen et al. 2002; Brusselmans et al. 
2005). 
 
Flavonoids 
Flavonoids constitute one of the largest groups of polyphenolic plant secondary 
metabolites with 15 carbon atoms arranged in a 3-ring structure (Figure 1). The 3-ring structures 
of flavonoids are labeled A, B, and C with a defined numbering of the carbon atoms. Rings A 
and B are benzene rings joined by a C3 linkage (C6-C3-C6).  The level of oxidation of the C3 
ring divides flavonoids into different classes and this difference in oxidation is reflected in the 
18 
 
chemical properties of each class (Owens and McIntosh 2010 and ref. therein). The different 
flavonoid classes include chalcone, aurone, flavone, flavanone, isoflavone, flavonol, 
dihydroflavonol, and anthocyanidin (Figure 1). 
Being polyphenolics, flavonoids have free hydroxyl groups on the rings through which 
different types of modifications occur resulting in a wide array of different types. Different 
substitutions may occur on different ring positions.  Over 5000 different flavonoids were 
described by 2004 but ~5000 more have been described since then giving a total of ~10,000 
flavonoids (Holden 2004 and ref. therein; Dixon and Pasinetti 2010 and ref. therein; Martens et 
al. 2010 and ref. therein).  This diversity is as a result of the different types of modifications such 
as glycosylation, methylation, and acetylation on the free hydroxyl group of these compounds 
among others. 
 
Roles of Flavonoids in Plants 
Plants produce an array of secondary metabolites among which are the flavonoids. 
Flavonoids are ubiquitous in higher plants and are commonly found in fruits, vegetables, nuts, 
seeds, stems, flowers, roots, and leaves (Cushnie et al. 2005). These flavonoids have beneficial 
biological roles in plants. 
19 
 
  
Figure 1. Chemical Structure of Flavonoids. A.  Basic structure and numbering pattern of 
flavonoids. B. Flavonoid classes and examples based on different substitution patterns at 
different ring positions (Lin 2011 and ref. therein). 
 
B 
A 
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Plants are often exposed to harsh environmental conditions not favorable for growth. One 
of such is the increase in UV radiation in the biosphere that causes serious damage to plants. UV 
radiation is known to damage DNA, RNA, and proteins (Li et al. 1993 and ref. therein). It is also 
known that phenylpropanoid gene expression is induced in the presence of UV light (Li et al. 
1993 and ref. therein). The phenylpropanoid pathway leads to the synthesis of flavonoids. 
Experiments have been carried out that show that plants are less tolerant to UV radiation when 
the synthesis of flavonoids is hindered. For example Arabidopsis flavonoid mutants that had 
mutations in the chalcone synthase gene (tt4) and chalcone isomerase gene (tt5) were shown to 
be hypersensitive to UV radiation when compared to wild type plants (Li et al. 1993). Flavonoids 
absorb this UV radiation and reduce the damage caused by it. High accumulation of quercetin-3-
glycoside was observed in the skin of apples after being exposed to high UV, and it is worth 
noting that once these glycosides were synthesized in response to high UV exposure, they were 
retained for prolonged periods even when stored in darkness (Solovchenko and Schmitz-Eiberger 
2003).  
The idea that flavonol glycosides tend to be retained can be linked to recent 
investigations that show a decreasing level of expression of a flavonol glucosyltranferase gene in 
grapefruit leaves that is highly expressed in Stage 2 (young) cotyledons but not expressed in 
stage 3 (older) cotyledons (Daniels et al. 2011). This glucosyltransferase catalyzes the synthesis 
of flavonol 3-O –glucoside (Owens and McIntosh 2009). The flavonol glucosyltransferase gene 
is again expressed in stage 3 first
 
(young) true leaves but not in stage 4 first true (older) leaves. 
The expression of this gene, however, increases again at stage 4 second true (young) leaves and 
in stage 5 young leaves (Daniels et al. 2011) probably due to increase in size of leaves and 
requirement for more quercetin glucoside to act as a sunscreen. Stage 2 refers to the appearance 
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of the first cotyledons, stage 3 to the appearance of the first true leaves, stage 4 to the first 
appearance of the second set of true leaves, and stage 5 refers to 1-4 year old plants (Daniels et 
al. 2011). 
Plants also face problems such as bacterial and fungal infections. Flavonoids act as 
phytoalexins fighting off infections of plants by such microorganisms (Cohen et al. 2001 and ref. 
therein). Several classes of flavonoids have been shown to have antimicrobial activity (Bylka et 
al. 2004). The antimicrobial role of flavonoids was first determined from plants used by lay 
healers and physicians to treat human disease (Cowan 1999; Cushnie et al. 2005 and ref. therein). 
When the content of such plants were investigated, they turned out to have a high concentration 
of flavonoids. Leaves of alfafa contain a high concentration of  isoflavonoid glycosides that upon 
infection with a fungal pathogen Ascochyta imperfeti are broken down by  glucosidase activity to 
the corresponding aglycone that then act as phytoalexins preventing the spread of the pathogen 
(Cohen et al. 2001and ref. therein). Earlier studies had shown an increase in the mRNA 
expression of core enzymes involved in the phenylpropanoid pathway leading to the synthesis of 
flavonoids in response to fungal elicitor, wounding, and infection of beans (Mehdy and Lamb 
1987 and ref. therein; Dixon et al. 2002 and ref. therein). 
Propolis, a resinous material produced by cone-bearing plants, has a high flavonoid 
content especially galangin and pinocembrin (Cushnie et al. 2005). The high concentration of 
these flavonoids has been attributed to the antimicrobial properties of this plant material 
(Cushnie et al. 2005). These flavonoids have been shown to have different mechanisms by which 
they carry out their antimicrobial functions such as inhibition of nucleic acid synthesis 
(myricetin), inhibition of cytoplasmic membrane function (sophoraflavanone G), as well as 
inhibiton of energy metabolism (licochalcone A and C) (Cushnie et al. 2005). Some flavonoids 
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have also been shown to have antifungal activities acting as inhibitors of spore germination of 
plant pathogens (Cushnie et al. 2005 and referenced therein). Galangin, a flavonol found in 
propolis, has also been shown to have inhibitory activity against Aspergillus flavus (Cushnie et 
al. 2005 and ref. therein). 
Acting as feeding deterrents, flavonoids tend to protect plants from herbivory and 
harmful insects that may cause considerable damage to the plant. To determine flavonoids with 
such properties, the feeding activity of insects are tested against these flavonoids. Several classes 
of flavonoids are known to act as feeding deterrents. For example, 9 isoflavonoids isolated from 
legume plants were shown to be feeding deterrents against 2 pasture scarabs, Costelytria 
zealandica and Heteronychus arator that cause severe economic damage to crops (Iwashina 
2003 and ref. therein). Several other classes of flavonoids have also been shown to have 
antifeeding characteristics such as flavones, flavanones, flavonols, and dihydroflavonols 
(Iwashina 2003 and ref. therein). The bitterness of grapefruit in part is due to the flavanone 
naringin which is highly accumulated in young grapefruit tissues making up to 40-70% of the 
dry weight of young green fruits and leaves (Jourdan et al. 1985; McIntosh and Mansell 1990). 
The bitterness of grapefruit may serve as a feeding deterrent (Benavente-Garcia et al. 1997), 
although the compound is also found in juice (Mansell et al. 1983). 
Pollination, in part, is carried out by insects, bats, and birds and this is very important in 
plant sexual reproduction. Seed dispersal is carried out by insect and animals (Cohen et al. 2001 
and ref. therein). Most insects and animals are attracted to plants that portray beautiful colors and 
odors (Miller et al. 2011). Plant fruits and flowers have different colors depending on the kind of 
pigment present in these plants (Miller et al. 2011). For plants to be colored, the pigments must 
reflect light in the visible range. Anthocyanins act as visible pigments (orange, red, purple, and 
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blue) that attract insects, other pollinators, and seed dispersers (Iwashina 2003; Miller et al. 2011 
and ref. therein). Some flavonoids act as pollinator attractants even though they are not visible 
pigments. For example, flavones and flavonols absorb light in the UV range but are still capable 
of acting as pollinator attractants due to the fact that some insects can discriminate UV light 
(Iwashina 2003). 
Flavonoids have also been shown to play a role in pollen germination (Ylstra et al. 1992; 
Miller et al. 1999). Hence, they are not just only involved in attracting pollinators but play a 
central role in this process by being directly involved in the formation of these plant structures 
that help propagate the species in which they are involved. Flavonols are required for plant 
pollen germination in maize and petunia (Miller et al. 1999). The flavonol 3-O-
galactosyltransferase gene is expressed exclusively in the male gametophyte of Petunia hybrida 
and controls the formation of a glycosylated flavonol that plays a role in pollen germination 
(Miller et al. 1999). It is worth noting that the same enzyme is not expressed in the female 
gametophyte (Miller et al. 1999). Flavonol-deficient plants have been shown to be self-sterile 
because the pollen fails to germinate or produce a functional tube but, when complemented with 
flavonol, the sterility was reversed indicating that flavonols play a key role in pollen germination 
(Taylor. 1997). 
Flavonoids also play important roles in interaction of plants with other organisms such as 
microbes that are important for plant survival. For example, nitrogen-fixing symbiotic bacteria 
play an important role by providing fixed nitrogen to the plants. The plants then provide nutrients 
for the nitrogen-fixing bacteria (Cohen et al. 2001). Some N2-defficient plants have been shown 
to produce flavonoids that attract nitrogen-fixing symbionts (Cohen et al. 2001 and ref. therein). 
For example, N2-deprived alfafa increase the secretion of flavonoids from their roots and  
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Rhizobium meliloti a N2-fixing bacteria has been shown to be attracted to alfafa-derived luteolin, 
4’,7-dihydroxyflavone, 4’,7-dihydroxyflavanone, and 4,4’-dihydroxychalcone (Cohen et al. 2001 
and ref. therein; Walker et al 2003  and ref. therein). Investigations have shown that these same 
compounds act as inducer for the R. meliloti nodulation genes (Cohen et al. 2001 and ref. 
therein). Earlier studies also identified flavonoids in the root exudates of legumes as one of the 
molecules that induced root nodulation in R. meliloti (Peters and Long 1988; Walker et al. 2003 
and ref. therein). 
Flavonoids are also implicated in plant-plant interaction acting as agents of allelopathy 
(Iwashina 2003 and ref. therein). Communication between plants is vital for their survival as they 
tend to compete for nutrients and other growth requirements such as water and light. Some plants 
secrete allelochemicals that prevent the germination of seeds of that same plant or related plant 
species thus reducing competition for growth nutrients. For example, leaf and stem extracts of 
Trifolium pretense with high isoflavonoid content have been shown to inhibit the germination of 
its own seeds and those of its close relatives T. repense and T.hydrium (Iwashina 2003 and ref. 
therein). Ten isoflavones and their glycosides were identified in the extract. Frond exudates of 
Pityrogramma spp. contain 2’,6’- dihydroxy-4’-methoxychalcone, 2’,6’-dihydroxy-4’- 
methoxydihydrochalcone, and  izalpinin that inhibited spore germination and gametophyte 
development of Pityrogramma calomeranos (Iwashina 2003 and ref. therein). However, at some 
concentrations these compounds acted as stimulants for spore germination (Star 1980). 
 
Roles of Flavonoids in Human Health 
Flavonoids play important roles in human health. Most of the health benefits to humans 
are due to their ability to act as antioxidants or being able to interact and inhibit enzymes 
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involved in disease processes (Cook and Sammons 1996 and ref. therein; Brusselmans et al. 
2005; Zhang et al. 2010). Most of the health benefits have been learned from epidemiological 
studies as well as in vitro experiments. For example, epidemiological studies have shown a 
protective effect of vegetables and fruits against cancer (Hollman et al. 1999 and ref. therein). 
Flavonoids are ubiquitously expressed in plants, and vegetables and fruits are dietary sources of 
these compounds. 
Consumption of food products containing high amounts of flavonoids has been shown to 
lower the risk of various cancers and their mechanisms of action have been investigated. One of 
the mechanisms is by induction of cancer cell apoptosis (Brusselmans et al. 2005). Brusselmans 
and his colleagues discovered that this apoptosis was brought about by inhibition of the fatty acid 
synthase (FAS) activity required for the production of long chain fatty acids in cancer cells. Up-
regulation of FAS occurs during early tumor development and RNA interference-mediated 
silencing of FAS had earlier been shown to inhibit lipogenesis leading to growth arrest and 
apotopsis of prostate cancer cells (De Schrivjer et al. 2005). Normal cells, on the other hand, 
have low levels of FAS because they obtain most of their saturated fatty acids from the diet. 
Some flavonoids that were shown to have anti-FAS activity were quercetin, luteolin, and 
kaempferol (Brusselmans et al. 2005). 
Free radicals generated from cell processes pose a great problem to human health such as 
coronary heart disease and stroke (Cook and Sammons 1996 and ref. therein; Vaya et al. 2003 
and ref. therein). Ness and Powles (1997), through epidemiological studies, showed that 
consumption of fruits and vegetable had a strong protective role against stroke and a weaker 
protective effect for coronary heart disease. For example, there is evidence that peroxidation of 
low density lipoproteins (LPO) is positively associated with atherogenesis (Cook and Samman 
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1996 and ref. therein). Peroxidation of LPO is brought about by free radicals and flavonoids have 
been shown, in vitro, studies to scavenge these radicals. This is an example of flavonoids acting 
as antioxidants (Cook and Sammons 1996 and ref. therein). Flavonoids also act as chelators of 
metals required for chemical reactions that produce reactive oxygen species and thus are capable 
of protecting and regenerating natural antioxidants such as tocopherols (Vaya et al. 2003 and ref. 
therein). Because LDL lipoperoxidation is the initiation step in atherogenesis, flavonoids are 
capable of preventing atherogenisis through their free radical scavenging activity or chelating 
properties. 
The process of wound repair in animals requires the presence of oxygen and oxygen 
therapies are being used for wound healing (Sen et al. 2002). Molecular oxygen plays a central 
role in the pathogenesis and therapy of chronic wounds (Shetty et al. 2007). The production of 
reactive oxygen species as this molecular oxygen is used can lead to cytotoxicity and delay in 
wound healing (Senel et al. 1997). Ocimum sanctum is a plant that has been used for the 
traditional treatment of wounds (Shetty et al. 2007 and ref. therein). The chemical composition 
of this plant was investigated and the study of 12 different plant flavonoids (mainly orientin and 
vicenin) from this plant revealed that they had both in vitro and in vivo antioxidant properties 
(Shetty et al. 2007).  The ability of these flavonoids to eliminate the reactive oxygen species was 
associated with the wound healing property of this plant (Shetty et al. 2007 and ref. therein). 
Flavonoids have also been shown to have antiviral properties. Some flavonoids such as 
quercetin have been shown to be inhibitors of reverse transcriptase of RNA viruses. This is very 
important because current inhibitors of this enzyme, such as acyclovir, are very toxic to all cells 
and not only to virally infected cells (Havsteen 2002 and ref. therein). Flavonoids also have the 
potential of stimulating the production of interferons which fight against viruses (Havsteen 2002 
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and ref. therein). For example, Trollius chinensis Bunge is a flower used in China for the 
treatment of upper respiratory infections (Li et al. 2001). The antiviral activity of flavonoids 
isolated from this plant were tested and 2 flavonoids, orientin and vitexin, exhibited potent or 
moderate activity against Para 3 virus (Li et al. 2001). 
 
Flavonoid Biosynthesis 
 
The biosynthesis of flavonoids occurs through the phenylpropanoid pathway that gives 
rise to a variety of plant natural products. The first enzyme of this pathway is phenylalanine 
ammonia-lyase (PAL) that plays a crucial role at the interface between plant primary and 
secondary metabolism (Koukol and Conn 1961; Maier and Hasegawa 1969). Koukol and Conn 
first referred to the enzyme as phenylalanine deaminase because the enzyme catalyzed the 
deamination of phenylalanine to form trans-cinnamic acid (Koukol and Conn 1961). Cinnamate-
4-hydroxylase (C4H), that requires NADPH and Cytochrome P-450 for its activity, catalyzes the 
4-hydroxylation of cinnamic acid to produce p-coumaric acid (Potts et al. 1974). This is followed 
by the formation of 4-coumaryl CoA from p-coumaric catalyzed by 4-coumarate: CoA ligase 
(Ragg et al. 1961). All steps mentioned are summarized in Figure 2. 
 
 
 
 
 
Figure 2. Formation of 4-Coumaryl CoA from Phenylalanine (Koukol and Conn 1961; Ragg et 
al. 1961; Maier and Hasegawa 1969; Potts et al. 1974). 
 
C4H ligase 
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Chalcone synthase (CHS) catalyzes the condensation of 3 molecules of malonyl CoA and 
one molecule of 4-coumaryl CoA (Figure 3) to form naringenin chalcone (Heller and Hahlbrock 
1980). It is considered to be the key enzyme in flavonoid biosynthesis as it catalyzes the 
formation of the first flavonoid which serves as a backbone for the synthesis of other flavonoids. 
It was earlier referred to as flavanone synthase (Kreuzaler et al. 1979; Kreuzaler et al. 1983 and 
ref. therein) but was later changed to chalcone synthase after it was realized that the final 
reaction product is naringenin chalcone (tetrahydroxychalcone) and not naringenin flavanone 
(Heller and Hahlbrook 1980). This was probably because tetrahydroxychalcone undergoes 
spontaneous cyclization to form flavanone. 
 
                                                                                                                                                                                                                                  
                   
 
 
 
Figure 3. Formation of Naringenin Chalcone (Kreuzaler et al. 1979; Heller and Hahlbrock 1980). 
 
Isomerization of chalcone to flavanone is catalyzed by chalcone isomerase (CHI) (Figure 
4). This enzyme catalyzes the intramolecular cyclization of bicyclic chalcones into tricyclic 
flavanones (Moustafa and Wong 1966). This enzyme was referred to as chalcone cyclase by 
Raymond and Maier after purifying and characterizing the enzyme from Citrus paradisi 
(Raymond and Maier 1977; Jez and Noel 2002 and ref. therein; Mehdy and Lamb 1987 and ref. 
therein) 
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Figure 4. Cyclization of Chalcones to Flavanone (Moustafa and Wong 1966) 
 
Flavanones then serve as a branch point for the formation of other flavonoids (Figure 5). 
Flavone synthase (FNS), a cytochrome P-450 dependent monooxygenase and NADPH-
dependent enzyme, catalyzes the formation of flavones from flavanone (Grisebach and Kochs 
1986). In the characterization of FNS from soybean cell cultures, it was realized that NADH 
could not substitute the requirement of NADPH by this enzyme (Grisebach and Kochs 1986). 
Two forms of FNS exist. One is FNS I which requires 2-oxoglutarate, O2, and Fe
2+
 for its activity 
whereas FNS II requires NADPH and O2 for its activity (Britsch et al. 1981; Grisebach and 
Kochs 1986; Martens and Mithofer 2006 and ref. therein). Isoflavone synthase (IFS) catalyzes 
the formation of isoflavone from naringenin and requires NADPH and O2 for its activity. The 
activity of this enzyme was found to be in the microsomal fraction (Grisebach and Kochs 1986). 
Flavanone 3-β-hydroxylase (F3H) catalyzes the conversion of flavanone to dihydroflavanol 
(Britsch et al. 1981; Britsch and Grisebach 1986; Pelt et al. 2003). Conversion of flavanones to 
flavone, dihydroflavonol, and flavonol was observed in cell cultures of parsley in the presence of 
2-oxoglutarate, Fe
2+
, and ascorbate (Britsch et al. 1981).   
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Figure 5. Flavonoid Biosynthetic Pathway (adapted from Heller and Forkmann 1988). CHI= 
chalcone isomerase (Moustafa and Wong 1966; Raymond and Maier 1977), IFS= Isoflavone 
synthase (Kochs and Grisebach 1986) FSI= flavone synthase (Britsch et al. 1981; Grisebach and 
Kochs 1986), F3H= flavanone 3β-hydroxylase (Britsch et al. 1981; Britsch and Grisebach 1986; 
Pelt et al. 2003), DFR= dihydroflavonol 4-reductase (Stafford and Lester 1982), FLS= flavonol 
synthase (Britsch et al. 1981; Lukacin et al. 2003), ANS=anthocyanidin synthase (Heller et al. 
1985; Saito et al., 1999), and F3GT= flavonoid 3-O-glucosyltransferase. (Heller et al. 1985; 
Fukuchi-Mizutani et al. 2003; Owens and McIntosh 2010). 
 
Synthesis of flavonols is catalyzed by the enzyme flavonol synthase (FLS) and it is a 2-
oxogluatarate dependent dioxygenase acting on dihydroflavonols to yield flavonols (Britsch et al. 
1981; Britsch and Grisebach 1986 and ref. therein; Lukacin et al. 2003). Dihyroflavonol 
reductase (DHR) converts dihydroflavonol to leucoanthocyanins from which anthocyanidins and 
anthocyanins are formed by anthocyanidin synthase (ANS) and UDP-3-O-glucosyltransferase 
(Heller et al. 1985: Saito et al. 1999, Fukuchi-Mizutani et al. 2003).  
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Citrus Flavonoids 
  
Several classes of flavonoids have been found in Citrus spp. These classes of flavonoids 
include flavanones, flavones, flavonols, dihydroflavonols, and anthocyanidins, but the 
anthocyanidins are found only in blood oranges (Berhow 1998; Tripoli et al. 2007 and ref. 
therein). Among these different classes of flavonoids, the flavonols, flavones, and flavanones are 
the most abundant (McIntosh and Mansell 1990; Owens and McIntosh 2011) with the flavanones 
being the most common. Over 60 different individual flavonoids have been identified and a few 
examples are shown in Table 1(Benavente-Garcia et al. 1997; Berhow 1998). 
Citrus species are known to produce and accumulate high levels of flavonoid glycosides 
especially flavanone and flavone glycosides (McIntosh and Mansell 1990; Owens and McIntosh 
2011 and ref. therein). A good example of a prominent flavanone found in Citrus is naringin 
(flavanone diglycoside) which is a bitter compound (McIntosh and Mansell 1990 and ref. 
therein). Flavonoid composition is important in terms of the taste of fruits making them of 
interest because these fruits are of commercial importance. For example hesperidin forms 
sediments in juices resulting in undesired cloudiness, while naringin influences the bitterness of 
grapefruit juices (Kesterson and Hendrickson 1957, Hendrickson and Kesterson 1965; Mansell et 
al. 1983; Gattuso et al. 2007 and ref. therein). 
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Table 1. Some Principal Flavonoids Found in Citrus with Structure and Substitution Patterns 
(Benavente-Garcia et al. 1997, Berhow et al. 1998). 
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The distribution of these flavonoids within citrus tissues has been investigated and it has 
been confirmed that these flavonoids vary in concentration and type within the plant organs and 
tissues (Jourdan et al. 1985; McIntosh and Mansell 1997). For example, peels have been shown 
to have more flavonoids than seeds (Tripoli et al. 2007 and ref. therein). Flavanone glycosides 
have been found in the lemon seeds, and peels as well as tangerine seeds but are not present in 
the juices of these fruits (Tripoli et al. 2007 and ref. therein). The levels of flavanone glycosides 
naringin in Citrus paradisi and hesperidin in Citrus sinensis have been studied (Barthe et al. 
1987; Jourdan et al. 1985). These studies showed that naringin and hesperidin were most 
concentrated in the young leaves of grapefruit and orange, respectively, and interestingly that 
hesperidin was found only in orange and not in grapefruit while naringin is found in grapefruit 
and not in orange (Barthe et al. 1987; Jourdan et al. 1985). Distribution of naringin in juices of 
different grapefruit cultivars has been studied in an attempt to determine what cultivar is more 
suitable to extract juice for consumption as this is one of the bitter compounds responsible for the 
bitterness of grapefruit (Mansell et al. 1983). It was realized that there was a statistically 
significant difference in the amount of naringin in the different juice samples.  
Another importance of flavonoid composition of citrus is for human health benefits. 
These health benefits are mostly related to the antioxidant properties of flavonoids (Benavente-
Garcia et al. 1997). The antioxidant property is achieved through their antiradical, anti-
lipoperoxidation, and metal chelation activities (Tripoli et al. 2007 and ref. therein). Certain 
structural properties are important for the antioxidant properties of these flavonoids (Figure 6). 
The catechol structure of the B-ring confers greater stability to the aroxyl radicals and 
participates in electron dislocation, the 2, 3 double bond that is also involved in electron 
dislocation from the B ring, and the 3- and 5-hydroxyl groups (Tripoli et al. 2007 and ref. 
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therein). Other factors such as glycosylation, methylation, and free hydroxyl groups also 
influence the antioxidant properties (Benavente-Garcia et al. 1997). The health benefits of these 
compounds have drawn significant interest in the determination of citrus flavonoid composition 
and their properties (Benavente-Garcia et al. 1997; Tripoli et al. 2007 and ref. therein). 
 
 
 
 
 
 
Figure 6. Important Antioxidant Structural Properties of Flavonoids. A. Catechol structure in B-
ring. B. 2, 3 double bond. C. Presence of both 3 hydroxyl (a) and 5 hydroxyl (b) groups. 
(Benavente-Garcia et al. 1997; Tripoli et al. 2007). 
 
Glycosylation 
Glycosylation is the addition of sugars to compounds and this reaction is often catalysed 
by glycosyltransferases. Most glycosyltansferases are soluble proteins with a molecular weight 
between 45-65kDa under in vitro conditions (Vogt and Jones 2000 and ref. therein). 
Glycosyltransferases have been classified into subfamilies according to the degree of primary 
sequence identity and even though the primary structures of these enzymes are  poorly 
conserved, the limited crystallized glycosyltransferases available show a highly conserved 
secondary and tertiary structure (Osmani et al. 2008 and ref. therein). Family one 
glycosyltransferases contain the plant UDP –dependent glycosyltransferases which glycosylate a 
wide variety of small plant molecules (flavonoids, alkaloids, terpenoids, and others) using UDP-
activated sugars (Osmani et al. 2008 and ref therein). The activated sugar is usually UDP-glucose 
A B C 
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but other activated sugars such as UDP-galactose, UDP-xylose, UDP-mannose, and UDP-
glucuronic acid are also used by some enzymes (Vogt and Jones 2000; Osmani et al. 2008).  
Glycosylation leads to the structural and functional modification of bioactive compounds. 
It enhances water solubility, physicochemical stability, and bioactivity as well as influencing the 
taste qualities of these compounds (Paquette et al. 2003 and ref. therein; Noguchi et al. 2008; 
Wang 2009 and ref. therein; Owens and McIntosh 2009; Owens and McIntosh 2011 and ref. 
therein). Another important aspect is the substrate specificity exhibited by the different 
glycosyltransferases as well as transfer of specific types of sugars (Osmani et al. 2008; Owens 
and McIntosh 2011). Depending on the type of sugar used as well as position of glycosylation, a 
particular compound may exhibit different biological activity or chemical property.  
Glycosylation has several biological roles. With respect to flavor, this is a very important 
reaction in the Citrus spp. Naringin and narirutin are both formed by the rhamnosylation of 
naringenin 7-O glucoside (McIntosh and Mansell 1990; McIntosh et al. 1990; Bar-Peled et al. 
1991, Frydman et al. 2004). For naringin, rhamnosylation occurs on the 2-OH group of the 
glucose molecule while rhamnsoylation occurs on the 6-OH group of the glucose unit for 
narirutin. This difference in position of rhamnosylation gives rise to a bitter naringin and a 
taseteless narirutin (Owens and McIntosh 2011 and ref. therein). The synthesis of both 
compounds is illustrated in Figure 7. 
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Figure 7. Glycosylation of Flavonoids Influences Taste Properties in Citrus (adapted from 
Owens and McIntosh 2011). Bitter naringin and tasteless narirutin differ only in position of the 
rhamnosyl on the glucose moiety. (McIntosh and Mansell 1990; McIntosh et al. 1990; Bar-Peled 
et al. 1991, Frydman et al. 2004; Owens and McIntosh 2011 and ref. therein). 
 
Flavonoids are not always synthesized at the location where their activity is needed and 
as such must be transported to areas where they are needed (Zhao and Dixon 2009). Flavonoids 
are found in most plant cell compartments such as cytosol, vacuole, endoplasmic reticulum, 
chloroplast, nucleus, and small vesicles and may be transported from one compartment to 
another (Zhao and Dixon 2009). Anthocyanins are primarily found in the vacuole (Zhao and 
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Dixon 2009 and ref. therein).  Glycosylation is one of the many chemical modifications of 
flavonoids that enhance their transport (Zhao and Dixon 2009). Even though other requirements 
such as acylation are essential for the transport of flavonoids, glycosylation alone is sufficient for 
the uptake of most flavonoids into the vacuole through certain pumps (Zhao and Dixon 2009 and 
ref. therein). Analysis of phloematic fluids revealed that naringin and neohespeiridin are 
transported from one part of the tree to another (Castillo et al. 1992) but the effect of 
glucosylation on the transport of these compounds from tissue to tissue is yet to be investigated. 
Glycosylation has also been shown to play a vital role in anthocyanin pigmentation. A 
good example is the glucosylation of delphinidin (an anthocyanin) that is a required for the 
acylation of this compound (Fukuchi-Mizutani et al. 2003).  This results in stabilization as well 
as increasing the intensity of the blue color.  
 
Glucosylation and Glucosyltransferases 
Glucosylation is one of the most prominent glycosylations that occur in plant secondary 
product metabolism. This involves the transfer of a glucose sugar from a UDP-activated glucose 
molecules such as flavonoids (Owens and McIntosh 2009 and ref. therein; Owens and McIntosh 
2011). This reaction is catalyzed by a group of enzymes known as glucosyltransferases (GTs). 
An example of this type of reaction is illustrated in Figure 8 below. 
 
Figure 8. Synthesis of Quercetin 3-O-glucoside from Quercetin . Catalyzed by a Flavonol 3-O-
Glucosyltransferase isolated from Citrus paradisi (Owens and McIntosh 2009). 
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Glucosyltransferases share a loosely conserved motif known as the Plant Secondary 
Glucosyltransferase (PSPG) Box (Vogt and Jones 2000 and ref. therein). This motif recognizes 
and binds to the glucose moiety of UDP-glucose and helps bring about glucosylation of the 
acceptor molecule (Owens and McIntosh 2009). This motif spans 44 amino acids with some, not 
all, the amino acids conserved within different glucosyltranferases as shown in Figure 9 (Vogt 
and Jones 2000). The PSPG box is near the C-terminus of these enzymes. Despite similarities in 
the PSPG domain, the overall sequence identities of glucosyltransferases is low (Owens and 
McIntosh 2009 and ref. therein; Vogt and Jones 2000). For example, PGT 1 which is now 
thought to be a shorter version of PGT 9 was compared with a limonoid GT from Citrus unshiu, 
there was only a 33% identity for the entire sequence as opposed to 61% identity for the PSPG 
box region only (RoySarkar 2004). 
 
 
Figure 9. Consensus PSPG Box (adapted from Vogt and Jones 2000). Highly conserved amino 
acids in blue (identity>50%) or red (identity>80%) 
 
Origin of Putative Glucosyltransferase Clones 9 and 11 
Grapefruit has been shown to accumulate high levels of glucosylated flavonoids. It also 
contains almost all the enzymes involved in the core flavonoid biosynthetic pathway and has also 
been shown to have diverse glucosyltransferases (McIntosh and Mansell 1990; McIntosh et al. 
1990). This makes grapefruit a potential source for diverse glucosyltransferases clones.  
Several glucosyltransferase clones have been identified from Citrus paradisi using 
different approaches in the McIntosh lab and named PGT 1- 11 (RoySarkar 2004; Strong 2005; 
Mallampalli 2009; Lin 2011; Owens and McIntosh 2011).  Putative GTs are identified, 
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expressed, and biochemically characterized (Owens and McIntosh 2009). The expression levels 
of different putative genes in Citrus paradisi have been looked into and the levels expressed 
differ from tissue to tissue as well as at different developmental stages (Daniels et al. 2011). 
After identifying a putative glucosyltransferase, it is cloned into an expression vector 
such as pCD1 (Owens and McIntosh 20011 and ref. therein) and transformed into E.coli cells for 
expression of soluble proteins. The pCD1 vector is a modified version of the pET 32a altered 
such that the fusion tag can be cleaved off (Owens et al. 2008 and ref. therein). Following 
expression of these proteins, they are purified and their activities screened against flavonoids as 
well as other plant secondary metabolites. If activity is found with a substrate, then the kinetics 
of these different enzymes are also studied. 
Glucosyltransferases have been shown to be substrate specific and determining the 
substrate for each enzyme is also of interest to the lab. Plant UDP-dependent 
glycosyltransferases (UGTs) with high amino acid similarity and from the same family have 
been shown to function differently. For example UGT73A5 and UGT71F2 from Dorotheanthus 
bellidiformis show only about 20% overall similarity but glucosylate the same set of acceptor 
molecules (Osmani et al. 2008 and ref. therein). On the contrary, 2 UGTs from Allium cepa 
(AcUGT73G1 and AcUGT73J1) fall in the same family of UGTs but the former exhibits very 
broad acceptor specificity, whereas the latter has a very narrow specificity. Therefore, it is clear 
that substrate specificity cannot be predicted solely based on degree of amino acid sequence 
identity (RoySarkar et al. 2007, Osmani et al. 2008 and ref therein; Owens and McIntosh 2009; 
Owens and McIntosh 2011). Flavonoid GTs differ in substrate specificity with a few exceptions 
and this class of enzymes also exhibit different chemical properties such as pH optima and pI’s 
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(McIntosh 1990 and ref. therein). It is therefore necessary to express these proteins and screen 
for their activity against a wide array of substrates to assign biochemical function. 
The substrate specificity of one of these putative GT enzymes (PGT 7) was successfully 
determined using this method. This was flavonol 3-O-glucosyltransferase (GQ141630) with its 
preferred substrate being quercetin (Owens and McIntosh 2009). It also had 57.9% and 40.7% 
relative activity with kaempferol and myricetin, respectively, both of which are flavonols. It 
showed relatively low or no activity for other flavonoid classes indicating that this enzyme is 
flavonol specific. PGT 10 has also been successfully expressed and a wide array of substrates 
screened to test for substrate activity and specificity (Lin 2011). No GT activity was detected. 
One of the major problems faced with expression in E.coli has been the presence of 
inclusion bodies into which the protein of interest is packed in an insoluble form (Mallampalli 
2009, Owens and McIntosh 2011 and ref. therein). This has been observed for other recombinant 
glucosyltransferases (Owens and McIntosh 2009 and ref. therein). Despite this problem, 
sometimes enough soluble protein is obtained that can be used to test for the activity of the 
enzyme (Owens and McIntosh 2009). 
Several techniques have been used to identify new clones from C. paradisi. Techniques 
used include SMART RACE PCR to amplify genes from a cDNA library of young grapefruit 
leaves in which partial 5’ and 3’ sequences were obtained (Sibhatu 2003; Strong 2005; 
RoySarkar et al. 2007), full sequences obtained by PCR using clone specific primers and 
“walking out” to the gene ends, full length clones obtained by designing primers to the extreme 
ends and using PCR (Sibhatu 2003; RoySarkar 2004; Strong 2005; RoySarkar et al. 2007; 
Cantrell 2006; Epling 2007), directional cloning and screening of a grapefruit EST cDNA library 
(RoySarkar 2004), and mining the harvEST database which contains expressed sequence tags 
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(EST) from different Citrus species (Mallampalli 2009 and ref therein). Mallampalli (2009) 
showed that it was possible to obtain new clones by bioinformatic analysis of the harvEST 
database. Five new clones were identified that did not match or correspond to previously 
identified clones. Among these 5 candidate unigenes was Cit. 1332.1 corresponding to PGT 9. 
Clone specific primers were designed against these unigenes and 3 of them (PGT 9, PGT 10, and 
PGT 11) were successfully amplified from young grapefruit leaf cDNA. It is possible that the 
other 2 clones may not be expressed in grapefruit leaf as these enzymes have been shown to be 
expressed in a tissue specific manner, or that the genes are not conserved at the 5’ or 3’ termini. 
Because these genes are developmentally regulated as well, it is also possible that the stage of 
leaves used may not have been expressing at that developmental stage. Also, considering that the 
harvEST database consists of ESTs from different Citrus spp, the other 2 clones may be 
expressed in different Citrus spp and not grapefruit.  PGT clones 9 and 11 consensus sequences 
contained the conserved PSPG box motif confirming it to be a putative secondary product 
glucosyltransferase (Figure 10). Given that the harvEST database consist of ESTs from different 
Citrus spp. and that the sequence obtained from young grapefruit cDNA library differed from the 
consensus sequence only by one base suggests that PGT 9 may be evolutionary conserved within 
the different Citrus species (Figure 11).   
The unmodified PGT clones 9 and 11 sequences (Figures 11 and 12) were cloned into 
pCR4 TOPO vector and transformed into Top 10 competent E. coli cells (Mallampalli 2009). 
This served as a holding cell line for these sequences.  
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Figure 10. Alignment of PSPG box of Citrus Flavonoid Glucosyltransferases and  Putative Plant 
Secondary Metabolite GT Clones. PGT 1-6, 9-11. Citrus paradisi cv. Duncan putative 
glucosyltransferase. GQ141630. Citrus paradisi cv. Duncan flavonol 3-O-glucosyltransferase. 
AY048882. Citrus maxima flavonoid 1-2 rhamnosyltransferase. AY519364. Citrus sinensis 
putative flavonoid 3-O-GT. (*). Biochemically characterized. (x). Not a flavonoid 
glucosyltransferases based on current evidence.  The dark shaded regions show highly conserved 
amino acids and the shaded regions show less conserved amino acids (adapted from Owens and 
McIntosh 2009). 
 
 
PGT 9 was modified using primers designed against the 5’ and 3’ ends of the sequence, 
cloned into pCD1 vector, and transformed into E.coli for expression and characterization. 
Successful expression was achieved but most of it was packed in insoluble fraction as inclusion 
bodies (Mallampalli 2009). This has been one of the major challenges faced in the biochemical 
characterization of these enzymes. The amount of soluble protein obtained was not sufficient to 
test for activity. Different temperatures, culture media, and time postinduction of cultures were 
tested to optimize the production of soluble proteins but no significant change in the amount of 
soluble proteins was observed. Attempts were made to enrich the soluble protein fraction using  
immobilized metal affinity chromatography but not enough was obtained to be able to screen for 
GT activity (Mallampalli 2009). 
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Figure 11. Alignment of PGT 9 Consensus Sequence with that Amplified from Young Grapefruit 
Leaf cDNA. There was only one base difference at position 1260 shown in a rectangle 
(Mallampalli 2009). 
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PGT 11       ATGAGCAGTC CCCATGTTGT GGTAATACCG AATCCAGAAC AAGGGCATGT   
        
             AATTCCTTTA CTAGAGTTGT CACAAAATTT GGCCAAGCAT GGCCTGAGAA    
       
             TCACATTTGT GAACTCGGAG TATAATCACA ATCGGGTATT GGAATCATTA     
    
             GAAGGAAAGA ATTACATTGG GGAGCAAATC CATCTGGTGT CGATCCCTGA      
    
             TGGAATCGAA CCATGGGATG ACAGGAGTGA TATGAGAAAG TTGTTAGAAA   
 
             AACGTTTACA GGTTATGCCT GGAAAGCTGG AGGGGCTCAT AGAAGAGATC  
    
             CATGGAAGAG GAGGTGAAAA AATAGCTTGT CTCATTGCAG ATGGGGCAGC   
     
             GGGGTGGGCT ATTGAAGTCG CTGAGAAGAT GAAACTCAGG CGGGCGGTTG   
       
             TAGTGATAAC CTCAGCAGCA ACAGTGGCCT TGACATTCAG TATCCCTAAG   
        
             CTGATAGAGG ATGGGGTCAT TAACAGTAAC GGGACTCCAA TCAAGGAACA   
    
             AATGATTCAA TTGGCACCAA ATATGCCTGC AATAAGCACT GGAGAGCTAT  
      
             TTTGGACTCG CTTTGGTGAC TTGACCATGC AAAAAATCTT CTTTGATTTT  
      
             ATGGTGCAAA ACATGAGAGC GACGAGAGCG GTAGATTTCC AGTTATGCAA    
      
             CTCAACATAC GAGCTGGAGG GTGGAGCATT CAGTATGATT CCGGAGCTTC   
       
             TTCCAATAGG ACCACTTTTG GCGAGCAACC GGTTAGGAAA TTCAGCAGGA   
     
             TACTTTTTGC CAGAAGACTC AAAATGTGTG GAATGGCTAG ACCAACAGCA   
    
             AGCAAACTCA GTCATTTATG TTGCTCTGGG GAGCCACACG GTACTCGAGC  
      
             AAAATCAGTT CCAAGAATTA GCATTAGGAC TTGAAATCTG CAACAGAGCG  
         
             TTCTTATGGG TGGTGAGGCC AGATATTACC AATGATGCAA ATGATGCATA   
     
             CCCTGAAGGA TTTCGAGAGA GAGTAGCCGC TCGAGGACAG ATGATCAGTT   
     
             GGTCTCCTCA GCAGAAGTTT CTCACCCACC CTTCCATTTC CTGTTTCATG   
  
             AGCCACTGCG GTTGGAATTC CACCACGGAA GGTGTGAGCA ACGGAGTCCC  
       
             TTTCCTGTGT TGGCCATTCT TTGCTGACCA ATTCATGAAC ACCACCTACA  
        
             TTTGTGATGT TTGGAAGGTG GGATTGAGGC TTGAAAGAAA CCAAAGTGGT  
   
             ATTATCGGAA GAGAAGAAAT TAAGAACAAG GTGGATCAAG TGCTGGGTGA   
      
             TCAAAATTTT AAGGCAAGGG CCTTAAAGCT TAAGGAAAAA GCCCTCAGTA   
      
             GTGTCAGAGA AGGTGGTTCA TCCAACAAGG CAATTCAGAA TTTCGTTCAA  
 
             TCCATCAAGC AATGGCCCGC ATGA 
 
Figure 12. Full Length Sequence of PGT 11 Amplified from Young Grapefruit Leaf  cDNA 
(Mallampalli 2009). 
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Hypotheses 
 
This research is designed to test the hypothesis that PGT 9 is a plant secondary product 
glucosyltransferase specifically a flavonoid glucosyltransferase. This entails expression of the 
soluble recombinant protein in order to screen for its activity against a variety of citrus secondary 
metabolites especially flavonoids as these are highly accumulated in the glycosylated form. This 
research is also designed to test the hypothesis that PGT 9 is under biochemical regulation as 
previous studies have shown that these GTs are inhibited by UDP and activated by sulfhydryl-
blockers (McIntosh and Mansell 1990; McIntosh et al. 1990 and ref. therein; Vogt 2000). Results 
of cloning of PGT 11 into yeast for expression and biochemical characterization are reported in 
this work. 
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CHAPTER 2 
MATERIALS AND METHODS 
Materials 
Chemicals and Reagents 
Zeocin
TM
 , Luria-Bertani broth powder, agar powder, ampicillin sodium salt, 
chloramphenicol, isopropyl-ß-D-thiogalactopyranoside (IPTG), tris base, β-mercaptoethanol 
(βME), tetramethylethylenediamine (TEMED, electophoresis grade), ammonium persulfate 
(APS), coomassie brilliant blue, ponceau S, ethidium bromide (EtBr, 10 mg/ml) for DNA gel 
electrophoresis, nitro-blue tetrazolium chloride (NBT), Nitrocellulose membrane (0.45µm pore 
size), ethyleneglycol monomethylether, dimethylformamide, Whatman chromatography paper 
#3, 5-bromo-4-chloro-3'-indolyphosphate p-toluidine salt (BCIP), sodium phosphate (NaH2PO4 
· H2O), phenol, chloroform, isoamyl alcohol, 100% ethanol, acrylamide 40% solution 
(acrylamide:bis-acrylamide, 19:1), glacial acetic acid, peptone powder, yeast extract, and yeast 
nitrogen base powder were purchased from Fisher Scientific (Pittsburgh, PA). Amido black stain 
10B was purchased from Corning (Palo Alto, CA). Thioredoxin-tag (trx-tag) monoclonal 
antibody and goat anti-mouse IgG alkaline phosphatase (AP) conjugates were purchased from 
Novagen (Madison, WI). GoTaq DNA polymerase and 5 X green / colorless buffer for 
polymerase chain reactions (PCR), deoxyribonucleotide triphosphate (dNTP), T4 DNA ligase 
enzyme and ligation buffer, and restriction enzymes Xba1, Xho1, Kpn1, Apa1, and Bstx1 were 
purchased from Promega (Madison, WI). Mini Trans Blot system for Western blotting, Mini-
PROTEAN Tetra gel electrophoresis system, and micro pulser cuvettes were from Bio-rad 
(Hercules, CA). TALON Metal Affinity Resin was purchased from Clonetech (Mountain View, 
CA).  Amicon Centricon 30 centrifugal filters were purchased from Millipore (Billerica, MA). 
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All primers were synthesized by Integrated DNA Technologies. Lyticase enzyme from 
Arthobacter luteus (lyophilized powder) and acid washed glass beads (pore size 0.5mm) were 
from Sigma Aldrich. 
 
Cells and Vectors 
The pCD1 vector and E.coli BL21 (DE3) RIL cells were obtained from Brenda Winkel, 
at Virginia Polytechnic Institute and State University (Blacksburg, VA). One shot Top 10 
competent E.coli cells were purchased from Invitrogen (Carlsbad, CA). The pPICZA and 
pPICZAα vectors and X33 parent strain of Pichia pastoris were a kind gift from Sanja Roje at 
Washington State University (Pullman, WA). Competent yeast cells were prepared as described 
in the appendix. 
 
Kits 
Silver Stain Plus Kit was purchased from Bio-Rad (Hercules, CA). Wizard SV Gel and 
PCR clean-up system kit was from Promega (Madison, WI). TOPO TA Cloning® Kit was 
purchased from Invitrogen (Carlsbad, CA). QIAprep spin Miniprep kit and Quantum prep 
plasmid mididrep kit were purchased from Qiagen (Valencia, CA). 
 
Buffers 
IMAC elution buffer containing 10 or 150 mM imidazole, 0.3 M NaCl, and 5 mM BME 
in 50mM phosphate buffer (pH 7.5), IMAC equilibration/ wash buffer (containing 50mM sodium 
phosphate, 0.3M sodium chloride, and  5mM BME, pH 7.5) and IMAC MES (2-(N-morpholino) 
ethanesulfonic acid)  buffer (pH 5.0) were prepared as described in Appendix E. Tank (Tris-
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glycine-SDS) buffer (pH 8.3), transfer buffer (pH 8.3), TBS-T buffer, AP buffer (pH 9.5), TAE 
(Tris-Acetate EDTA) buffer, 50mM Tris-HCl buffer (pH 7.5), and 50mM phosphate buffer (pH 
7.5, containing 50mM βME) were prepared as described in the appendix. Breaking buffer 
(containing 50mM Sodium phosphate, pH 7.4, 1mM PMSF (phenylmethylsulfonyl fluoride), 
1mM EDTA (Ethylenediaminetetraacetic acid) and 5% glycerol), and PBS-T buffer were also 
prepared as described in the appendix. 
 
Culture Media 
LB (Luria-Bertani), low salt LB, YPDS (yeast extract peptone dextrose sorbitol), and 
YPD (yeast extract peptone dextrose) liquid media and plates were prepared as described in 
Appendix B. Buffered glycerol-complex media (BMGY) and buffered methanol-complex media 
(BMMY) were prepared as described in Appendix B. 
 
Substrates for Enzyme Screening Assays 
Chalcone (4, 2’, 4’, 6’-tetra-OH-chalcone), naringenin, hesperetin, apigenin, luteolin, 
kaempferol, quercetin, myricetin, 4’-methoxyflavonol, cyanidin, 4’-acetoxy-7-hydroxy-6-
methoxyisoflavone were from stock supplies of Dr. Cecilia A. McIntosh at East Tennessee State 
University (Johnson City, TN).  Eriodictyol, isosakuranetin, fisetin, gossypetin, diosmetin, 
scutellarein, umbelliferone, scopotelin, esculetin, sinapic acid, catechol, phloroacetophenone, 
and 2, 4-dihydroxybenzaldehyde were purchased from Indofine (Hillsborough, NJ). Vanillin, 2-
hydroxycinnamic acid, vanillic acid, 4-hydroxybenzoic acid, and gentisic acid were purchased 
from Sigma, (St. Louis, MO). Uridine-5’-diphospho-[U-14C]-glucose (UDP-G; 261 mCi/ mMol) 
was obtained from ICN (Irvine, CA). 
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Methods 
Optimization of Soluble Recombinant PGT 9 Expression in E. Coli 
Frozen cells of BL21 (DE3) RIL containing PGT 9 expression construct in pCD1 vector 
were inoculated using a sterile toothpick into 10ml of LB amp(100mg/L), chlr (34 mg/L) (Luria-Broth 
media containing ampicillin at 100 mg/l and chloramphenicol at 34 mg/l final concentration) 
liquid medium containing 2.5mM  betaine and 660mM sorbitol and incubated at 37
o
C, 250 rpm 
overnight.  The next morning, 100ml of fresh LB amp(100mg/L), chlr (34 mg/L) medium containing the 
same concentration of betaine and sorbitol was inoculated with 1ml of the overnight culture and 
grown at 37
o
C with shaking at 250 rpm to an OD600 between 0.5-0.7. A 1ml aliquot was removed 
to represent the preinduction culture sample. The remaining culture was treated with IPTG to a 
final concentration of 1mM, and the cultures were incubated at 25
o
C (250 rpm). Postinduction 
samples (500μl for total protein determination and 15mL for soluble protein isolation) were 
collected after 6, 8, 12, and 24 hours. The 500μl samples for determination of total protein were 
centrifuged at room temperature in an eppendorf centrifuge (Fisher Scientific) at 10,000 X g for 
10 minutes and pellets for SDS-PAGE stored at -20
o
C overnight. The 15ml samples for detection 
of soluble protein were centrifuged at 4oC in a Sorvall RC-5B refrigerated super speed centrifuge 
(Fisher Scientific) at 10,000 X g for 10 minutes to collect the cells. The supernatants were 
discarded and pellets were stored at –80ºC. Culture conditions such as temperature and time of 
sample collection were also altered in the experiment to determine the conditions with the 
highest soluble protein yield. Temperatures of 20
o
C, 25
o
C, and 30
o
C were used in combination 
with betaine and sorbitol. 
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Isolation of Total and Soluble Recombinant Proteins 
Total cellular protein was prepared for analysis as follows: the postinduction pellets were 
resuspended in 250μl of 2X SDS-PAGE sample buffer. Tubes containing resuspended pellets 
were vortexed to achieve complete resuspension, boiled for 15 minutes, and centrifuged at 
10,000 X g for 15 minutes at 4
o
C. A 200μl aliquot was transferred to a microcentrifuge tube and 
stored at -20ºC for SDS-PAGE analysis. 
Isolation of soluble protein was performed as follows. The postinduction cell pellets were 
removed from -80
o
C freezer, thawed, and resuspended in 1ml cold 50mM phosphate buffer (pH 
7.5) containing 14mM βME (β-mercaptoethanol). Cells were lysed by sonicating the 
resuspended pellets by pulsing on ice 10 times for 5s each with a 60s recovery using a sonic 
dismembrator model 500 with microtip (Fisher Scientific). The sonicated samples were 
centrifuged at 10,000 X g for 20 minutes at 4
o
C. The pellets were discarded and each supernatant 
was placed in a clean 1.5ml tubes and analyzed for expression of soluble rPGT 9 protein using 
SDS-PAGE and Western blotting. 
 
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
SDS-PAGE was performed as follows:  For total protein sample, 6μl of sample was 
mixed with 6μl of 2X SDS-PAGE, boiled for 5 minutes and centrifuged 1 minute at 10,000 X g. 
For the soluble protein sample, 15μl samples was mixed with 5μl of 4X SDS-PAGE sample 
buffer, boiled for 5 minutes, centrifuged for 1 minute at 10,000 X g. Broad range marker was 
diluted 20 folds by mixing 1μl of the stock with 19μl of 2X dye. For the prestained marker, 10μl 
was used. All samples and markers were analyzed on an acrylamide gel (5% stacking gel, 10% 
separating gel).  The samples were electrophoresed for 45 minutes at 200volts. 
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Western Blot 
Prior to Western blotting, the nitrocellulose membrane was soaked in transfer buffer 
(containing 20% methanol) for 20 minutes as recommended by the manufacturer. The SDS-
PAGE gel was placed onto the nitrocellulose membrane. The gel and membrane were 
sandwiched between paper and sponge and clamped tightly together after ensuring no air bubbles 
had been formed between the gel and membrane. The sandwich was placed in the transfer tank 
(containing an ice pack) and 1X transfer buffer (containing 20% methanol) was added and the 
gel was electroblotted for 1 hour at 100V. After 1 hour, the nitrocellulose membrane was stained 
with ponceau S stain for 1-2 minutes to visualize the protein markers. The area containing the 
protein markers was separated from the rest of the membrane using a clean razor blade. The 
ponceau S was removed by inserting the membrane in distilled water and shaking gently until all 
the stain was removed. 
The remaining membrane containing the samples of interest was blocked with 30ml of 
blocking solution (containing 1.5g of fat free milk powder and 3ml of 1X TBS-T) for 30 minutes 
at room temperature with gentle shaking. Next, the nitrocellulose membrane was washed with 
20ml of 1X TBS-T, 3 times for 5 minutes each, and then incubated in primary antibody at room 
temperature (2μl of Trx-tag monoclonal antibody in 10ml of 1X TBS-T) for 30 minutes with 
gentle shaking. After incubation, the membrane was washed with 20ml of 1X TBS-T, 3 times for 
5 minutes each, and then the membrane was incubated in secondary antibody (1μl of Goat Anti-
Mouse AP conjugate in 10ml of 1X TBS-T) for 30 minutes at room temperature with gentle 
shaking. The membrane was then washed with 20ml of 1X TBS-T, 5 times for 5 minutes each to 
remove unbound secondary antibody. Substrate solution was prepared as follows: 0.083g of NBT 
was mixed with 700μl of dimethylformamide (70%) and 300μl of distilled water. 0.042g of 
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BCIP was mixed with 1ml of dimethylformamide (100%). The developing solution was prepared 
by adding 60μl of the prepared BCIP and 60μl of the NBT to 15ml of AP buffer (7.5) to make up 
the developing solution. The developing solution was prepared 1 minute prior to usage. The 
developing solution was then poured over the washed membrane and watched closely for bands 
at room temperature while shaking gently. It took 6 minutes for bands to develop.  The reaction 
was stopped by rinsing with distilled water. 
 
Enrichment of Soluble Recombinant PGT 9 
Several attempts were made to enrich the soluble fraction of recombinant PGT 9 (rPGT 
9) using IMAC. Collection of samples at different times postinduction and as well as different 
culture temperatures (15ºC, 20ºC and 25ºC) were carried out. 
Cells were cultured at 25ºC and samples collected at 6 hours postinduction using the 
procedure described above. The –80ºC frozen cell pellet was thawed and resuspended in 10ml of 
lysis buffer (50mM phosphate buffer; 5mM βME). The resuspended sample was lysed using a 
French press 3 X at 2000 psi (Fisher Scientific) while keeping the sample on ice. The lysed 
sample was collected in a 50ml conical centrifugal tube and centrifuged for 20 minutes, 4ºC at 
13000 X g in a Sorvall RC-5B refrigerated superspeed centrifuge. The supernatant containing 
soluble rPGT 9 protein was transferred carefully into a fresh 50ml tube without disturbing the 
pellet and labeled “Crude”. 
Soluble rPGT 9 protein (crude) was enriched by immobilized metal affinity 
chromatography (IMAC) using the TALON system (TALON Metal Affinity User’s Manual, 
Version PR651843, Clontech). The enrichment was performed using 5ml column bed volume. 
The column was equilibrated with 10ml of equilibration wash buffer. A total of 10ml sample was 
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applied to the column and 2ml fractions were collected. After applying sample to column, the 
column was washed with 30ml of equilibration wash buffer and 5ml fractions were collected. 
Weakly bound proteins were eluted using 30ml of 10mM imidazole and 5ml factions collected. 
The tightly bound polyhistidine tagged proteins were eluted using 150mM imidazole buffer. The 
fractions were analyzed by SDS-PAGE and the gels silver stained using silver stain plus (Bio-
Rad) according to the manufacturer’s instructions. 
 
Expression of PGT 9 in Methylotropic Yeast (Pichia Pastoris) 
Cloning of PGT 9 into pPICZA and pPICZΑα Vectors 
Primer Design and Cloning Strategies. Primers were designed to modify the ends of PGT 
9 to introduce restriction sites found in the mulitiple cloning site (MCS) of pPICZA and 
pPICZAα vectors. Three different types of modifications were carried out requiring four primers, 
each primer introducing a different restriction site for digestion to obtain sticky ends. The primer 
combinations for the 3 different modifications are shown in Table 2. 
Clone 1 was modified for ligation with pPICZA vector for intracellular expression of 
PGT 9. There is no start codon upstream of the PGT 9 sequence when inserted into this vector. 
Transcription begins at the PGT 9 start codon hence a native N-terminal structure (Figure 13). 
Restriction enzymes used for digestion of modified PGT 9 and vector were Kpn I and Apa I 
(Table 2). The rPGT 9 would have a c-myc epitope and a polyHis tag (Figure 13). 
Clone 2 was modified for ligation with pPICZAα for secretion of expressed PGT 9. With 
this vector, rPGT 9 would be expressed with the secretory signal peptide attached to the N-
terminus but this signal is cleaved at the Kex2 cleavage site from the yeast cells. This design was 
such that 14 additional amino acid residues would be attached to the final rPGT 9 after cleavage 
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of the secretory signal hence the N-terminal would not be native (Figure 14). The set of 
restriction enzymes used for this clone were Kpn I and Xba I (Table 2). These enzymes do not 
cut within the PGT 9 sequence. rPGT 9 would be expressed with the c-terminal tags as well 
(Figure 14). 
Clone 3 was also designed for ligation with pPICZAα for secretion of expressed rPGT 9 
(Table 2). The difference between clone 2 and clone 3 is that the Kex2 cleavage site is 
introduced immediately adjacent to the rPGT 9 start codon such that cleavage of the secretory 
signal would leave a native N-terminal of rPGT 9 with no additional amino acids (Figure 15).  C-
terminal tags would also be present. 
Table 2. Primer Combinations and Restriction Sites Introduced. Green=linkers, 
purple=restriction sites, red=PGT 9 start codon, Blue=Kex2 cleavage site (site at which secretory 
signal is cleaved after secretion of heterologous protein into the media). 
 
 
 
 
 
 
 
Strategy Sense primer Antisense primer 
1 
 
pPICZA 
 
 
(CSP120F) (64⁰C)(Kpn I restriction site) 
5’CATGGGTACCATGGATCCAGCCGGAGCAAG 3’ 
 
 
 
(CSP121R)( 64⁰C)(Apa I restriction site) 
5’CGCGGGCCCGTGAAGGGTTTCGGTTCCGG 3’ 
 
2 
 
 
pPICZAα 
 
 
(CSP120F)  (64⁰C)(Kpn I restriction site) 
5’CATGGGTACCATGGATCCAGCCGGAGCAAG 3’ 
 
 
 
(CSP123R) (64⁰C)(Xba I restriction site) 
5’CGCTCTAGACGGTGAAGGGTTTCGGTTCCGG 3’ 
 
 
3 
 
 
pPICZAα 
 
(CSP122F) (64⁰C)(Xho I restriction site and Kex2 cleavage site) 
5’CATGCTCGAGAAAAGAATGGATCCAGCCGGAGCAAG 3’ 
 
 
 
(CSP123R) (64⁰C) (Xba I restriction site) 
5’CGCTCTAGACGGTGAAGGGTTTCGGTTCCGG 3’ 
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Figure 13: Cloning Strategy 1 for PGT 9. Recombinant PGT 9 expressed with a native N-
terminal but not secreted out of the yeast cells (modified from Invitrogen Manual). 
 
 
Figure 14. Cloning Strategy 2 for PGT 9. Recombinant PGT 9 expressed and secreted out of the 
yeast cells with 14 extra amino acids at the N-terminus (modified from Invitrogen Manual).Not 
drawn to scale. 
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Figure 15. Cloning Strategy 3 for PGT 9. Recombinant PGT 9 expressed and secreted out of the 
yeast cells with a native N-terminus (modified from Invitrogen Manual). Not drawn to scale. 
 
 
Plasmid (PGT 9-Topo) DNA Isolation from E.coli  
In order to modify ends of PGT 9, Top 10 E. coli cell containing unmodified PGT 9 in 
pCR4 TOPO were cultured in 10ml of LB amp(100mg/L) [Luria-Broth media containing ampicillin at 
100 milligrams/liter] overnight at 37
o
C, 250rpm. The next morning, a plasmid miniprep was 
carried out following the QIAprep Spin Miniprep kit protocol. Low salt LB media was also 
prepared (2.5g NaCl, 2.5g yeast extract, 5g tryptone, 12.5mg zeocin, pH 7.5) for culture of TOP 
10 cells containing pPICZA and pPICZAα vectors. A 10ml aliquot of this media was inoculated 
with the TOP 10 E.coli cells and cultured overnight at 37
o
C, 250 rpm and miniprep was carried 
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out the following morning. A 2μl aliquot of each miniprep sample was mixed with 3μl of water 
and 1μl of 6X dye. The sample was run on a 0.8% agarose gel at 100V for 30 minutes. 
 
PCR Modification of 5’ and 3’ Ends of PGT 9 
A stock concentration of 200μM for each primer was prepared by first mixing and then 
centrifuging the tubes containing the primers in an eppendorf centrifuge for 1minute at 10,000 X 
g and then adding the appropriate amount of sterile distilled water. A 20μM working solution 
(final volume of 50μl) was prepared by adding 5μl of stock solution to 45μl of sterile distilled 
water. The 200μM stock and 20μM working solutions of primers were stored at -20˚C. 
Plasmid DNA (PGT 9-TOPO) isolated from E. coli cells was used as template for a PCR 
amplification reaction using clone-specific primers as shown in Table 2. PCR tubes contained 
2.5ul of 20μM solution of each appropriate clone-specific primer (CSP), 2.5μl of a 1:1000 
diluted plasmid, 1μl of Taq polymerase, 10μl of 5X colorless buffer, and 31μl of sterilized 
deionized water. PCR steps, temperatures, and cycles are shown in Table 3. PCR products were 
analyzed using a 0.8% DNA agarose gel stained with ethidium bromide.  
 
TOPO Cloning of PCR Modified PGT 9 
PGT 9 PCR product was cloned into pCR
®
4-TOPO vector using the TOPO TA Cloning 
Kit (Invitrogen) according to manufacturer’s instructions. The TOPO cloning reaction consisted 
of 4μl aliquot of gel purified PGT 9 PCR products, 1μl of salt solution, and 1μl of TOPO vector 
and the reaction was incubated for 30 minutes at room temperature. The TOPO cloning reaction 
was subsequently transformed into One-Shot Top 10 competent E. coli cells as follows: a 2μl 
aliquot of the TOPO cloning reaction was transferred into tube containing 50μl competent cells. 
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The procedures for transformation were carried out following the manufacturer’s instructions 
(Invitrogen). For the positive ligation control, 1μl of pUC19 was added to 50μl of One-Shot 
competent cells. 
 
Table 3. PCR Steps Used in the Modification of 5’ and 3’ Ends of PGT 9. 
Step Temperature (
o
C) Time (seconds) # of Cycles 
Initiation 94 60 1 
Denaturation 94 30  
30 Annealing 64 30 
Elongation 72 120 
Final Elongation 72 300 1 
 
After transformation, 250μl of S.O.C medium was added to each transformation reaction. 
The reactions were then incubated at 37ºC at 225rpm for 1hour and 100 μl of culture containing 
transformation reaction was spread onto each LBamp(100mg/L) plate. For the pUC19 control, the 
transformation was diluted 1:10 into LBamp(100mg/L) liquid media and 100μl was spread on each 
LBamp(100mg/L) plate. Plates inoculated with the transformation samples were incubated overnight 
at 37°C. 
Individual colonies from the PGT 9-pCR4 TOPO transformed plates were carefully 
picked using a sterile toothpick and streaked onto plates containing LBamp(100mg/L) media to make 
replicates. The plate with cells containing PGT 9 modified with Kpn I/Apa I was labeled X. The 
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plate with cells containing PGT 9 modified with Kpn I/Xba I was labeled Y and that containing 
cells modified with Xho I/Xba I was labeled Z. As opposed to several colonies growing on plates 
X and Z, only 7 colonies grew on plate Y. Each toothpick was then immediately placed into a 
sterile 0.5ml eppendorf tube containing 100 μl of sterile distilled water. The samples were boiled 
for 5 minutes to lyse the cells and 1μl of cell lysate was added to 9μl of PCR master mix. The 
PCR master mix contained the following: 4μl of 10mM dNTPs, 10μl of 20μM T3 sense primer, 
10μl of 20μM T7 antisense primer, 40μl of 5 X green Go-Taq buffer, 94μl of sterile dH20, and 
2μl of Taq polymerase. The conditions for the PCR reaction were as previously described (Table 
3). Sterile dH2O was used in place of cell lysate as a negative control. The PCR products were 
analyzed using a 0.8% DNA agarose gel stained with ethidium bromide. 
Three positive colonies from each plate were T-streaked on selective LB amp(100mg/L)  agar 
plates to obtain single colonies. Single colonies were selected from the streaks and inoculated in 
10ml of LB amp(100mg/L), and grown overnight at 37
o
C at 250 rpm. From the overnight culture, 
500μl was collected and added to 500μl of sterile glycerol (50% glycerol final concentration) and 
stocks were stored at -80°C. From the remaining culture, 5ml was used to carry out minipreps 
using QIA prep Spin Miniprep Kit according to the manufacturer’s instructions to isolate 
plasmid DNA containing modified PGT 9. Plasmid DNA was eluted with 50μl of distilled water. 
A 2μl aliquot was mixed with 3μl of distilled water and 1μl of 6 X dye and analyzed on a 0.8% 
agarose gel stained with ethidium bromide.  
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Restriction Digest of Inserts and Vectors 
In order to confirm the presence of PGT 9 in the TOPO vector, digestion was also carried 
out using the appropriate pairs of restriction enzymes. A 2μl aliquot of miniprep plasmid DNA 
from colonies having the different modified PGT 9 sequences were digested. The digestion mix 
was made up of 2μl of plasmid, 1μl of appropriate buffer, 1μl of each restriction enzyme, and 5μl 
of distilled water. This was incubated at 37°C for 2 hours. Each digest was then analyzed on a 
0.8% agarose gel stained with ethidium bromide. After 2 hours, 1μl of each enzyme was added to 
the digestion mix and incubated again for 2hours. Once plasmids were confirmed to have the 
modified PGT 9 sequences by agarose gel electrophoresis using a 0.8% agarose gel, one colony 
for each modification was selected for further use. Colony X6 (Kpn I/Apa I restriction site), Y2 
(Kpn I/ Xba I restriction sites), and Z13 (Xho I/ Xba I restriction sites) were selected.  
In order to carry out ligation reactions, larger volume restriction digests of the rPGT 9 
plasmids with corresponding vectors were carried out (Table 4). From the minipreps, 16μl of 
each insert (PGT 9-TOPO) and each vector were digested with restriction enzymes to obtain 
sticky ends for ligation. After incubating the digestion mix at 37
o
C for 2hours, 1μl of each 
enzyme was added to the reaction and incubated for another 2hours at 37
o
C. This was to ensure 
complete digestion of the inserts and vectors. X6 and pPICZA were digested with Kpn I/Apa I, 
Y2 and pPICZAα were digested with Kpn I/Xba I and Z13 and pPICZAα were digested with 
Xho I/Xba I (Table 4). The digestion reactions were stopped by incubating the tubes at 65
0
C for 
5 minutes. The entire sample from each digestion reaction was loaded onto a 0.8% agarose gel. 
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Table 4. Digestion Reaction Set-up for Different Cloning Strategies for PGT 9. 
Ligation  
Pair 
Insert/Vector 
(16μl of each) 
Restriction Enzymes 
(1μl of each) 
Buffer 
(2μl of each) 
 
A 
X6 Kpn I/Apa I A 
pPICZA Kpn I/Apa I A 
 
B 
Y2 Kpn I/ Xba I A 
pPICZAα Kpn I/ Xba I A 
 
C 
Z13 Xho I/ Xba I D 
pPICZAα Xho I/ Xba I D 
 
PGT 9 and vector bands were cut out of the agarose gel and gel purified following the 
Promega Wizard SV Gel and PCR clean-up system. From the gel-purified bands, 2ul and 5ul of 
each insert and vector were loaded on a 0.8% agarose gel as previously described alongside 
quantitative Lambda/Hind III and 1kb plus exACTGene DNA markers to determine the 
concentration of each and also to confirm the size of the insert and vectors. The concentrations of 
each gel purified digest were determined and recorded in Table 5. 
 
Ligation of Digested PGT 9 with Vectors and Transformation into Top 10 Competent E.coli 
After determining the concentration of the vectors and insert, ligations were carried out 
using different molar ratios (insert:vector) of 1:1, 3:1, and 6:1. The ligation mix was incubated at 
15
o
C for 4hours. The concentrations of each digested rPGT 9, pPICZA and pPICZAα were 
determined and are recorded in Table 5. The different volumes used for the different ratios and 
different cloning strategies are shown in Tables 6, 7, and 8.  
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Table 5. Concentration of Vectors and Inserts Used During Ligation for Each Cloning Strategy 
as Determined Using Quantitative DNA Marker. 
 
Strategy Vector/ Insert Concentration (ng/μl) 
 
1 
X6 
pPICZA 
18.0 
16.5 
 
2 
Y2 
pPICZAα 
15.5 
13.0 
 
3 
Z13 
pPICZAα 
15.5 
18.0 
  
The different volumes used in the ligation procedure were calculated using a formula 
provided in the Promega catalog (Part# 9PIM180) as shown below.  
 
 
 
A total of 100ng of vector was used as recommended in the user manual (Promega catalog, Part# 
9PIM180catalog). The volume corresponding to this was also calculated by simply dividing the 
required amount (100ng) by the concentration of the vector. Least possible volumes were used 
for each ligation procedure. 
 
 
 
 
63 
 
Table 6. Reaction Mixtures for Ligation of pPICZA Vector and PGT 9 Insert (Strategy 1) 
Ratio of          Volume           Volume           Volume           Volume       Volume          Total 
Insert to    of insert of vector     of T4 DNA     of ligase of sterile         volume 
 Vector (µl)     used (µl) used (µl)        ligase (µl)      buffer (µl) water (µl)    (µl) 
1:1    1.23    3.2      1      1     3.57               10 
3:1    3.7    3.2      1      1      1.1   10 
6:1    7.4    3.2       1      1.5      1.9   15   
 
Table 7. Reaction Mixtures for Ligation of pPICZAα Vector and PGT 9 Insert (Strategy 2) 
Ratio of          Volume           Volume            Volume          Volume           Volume  Total  
insert to          of insert of vector     of T4 DNA     of ligase of sterile  volume 
vector            used (µl) used (µl)        ligase (µl)      buffer (µl) water (µl)      (µl) 
1:1    2.7    7.7      1      1.5      2.1               15 
3:1    7.9    7.7                 2      2.1      1.3   21 
36:1     15.8    7.7      2      3.0       1.5   30   
Table 8. Reaction Mixtures for Ligation of pPICZAα Vector and PGT 9 Insert (Strategy 3). 
Ratio of          Volume           Volume       Volume            Volume       Volume  Total  
insert to    of insert of vector     of T4 DNA     of ligase of sterile  volume 
vector            used (µl) used (µl)        ligase (µl)      buffer (µl) water (µl)      (µl) 
  1:1    2.7    5.6      1      1.2       1.5               12 
  3:1    7.9    5.6                 2      1.9       1.6   19 
  6:1    15.8    5.6      2      2.6        -     26     
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After the ligation reactions were incubated, 2µl of the products were transformed into 
separate aliquots of Top10 E. coli cells to serve as holding cell lines. The procedure for 
transformation was as described before, but only 16.6µl of Top10 cells were used for each 
transformation using the heat shock method. After adding 2µl of the cloning product to the 
16.6µl of Top10 cells, it was incubated on ice for 30 minutes. The cells were then heat shocked 
at 45
o
C for 30 seconds and incubated on ice again for 2 minutes. Plain low salt LB was added to 
the transformation sample instead of SOC media due to high salt concentration in the SOC media 
which could inhibit the antibiotic zeocin leading to false positives. Because the volume of Top10 
cells used was only 16.6µl, 83.3µl of the low salt LB was used to resuspend the cells. They were 
incubated at 37
o
C in a vertical position for 1 hour while shaking at 225rpm for the cells to 
recover.  For the negative control, 1µl of pUC 19 was transformed into 16.6µl of Top10 cells and 
the heat shock process followed as described. After, 1 hour of recovery, 100µl of the cells were 
evenly plated on pre-warmed LBzeocin (25mg/L) agar plates and incubated overnight at 37
o
C. A 1:10 
dilution for the cells transformed with pUC 19 was carried out and a 100µl aliquot was evenly 
plated on low salt LBzeocin (25mg/L) to serve as the negative control. 
 
PCR Screening for Positive Colonies 
PCR screens were used to screen colonies that had grown overnight at 37
o
C on the 
selective low salt LBzeocin (25 mg/L). To confirm transformation, colonies were selected at random 
from the different plates containing cells transformed with different ligation ratios. Sterile 
toothpicks were used to select these colonies and each colony was resuspended in 100µl of 
sterile dH2O and then streaked on a selective LBzeocin (25mg/L) to make replicates. The samples 
were boiled for 5 minutes to lyse the cells and release the vector which should contain the insert 
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if the ligation procedure was successful. This was used as the template for the PCR reaction. 
Clone-specific primers were used in the PCR reaction to amplify the inserts if they were present 
in the vector. A master mix was prepared as previously described in “TOPO CLONING OF PCR 
MODIFIED PGT 9” using the clone-specific primers corresponding to each cloning strategy; all 
primers had an annealing temperature of 64
o
C. Same PCR cycles in Table 3 were used and the 
final PCR product analyzed on a 0.8% agarose gel. Positive colonies were selected from the 
plates that contained the replicates and T-streaked on selective low salt LBzeocin (25 mg/L) plates to 
get single colonies. Single colonies obtained were subsequently cultured overnight at 37
o
C while 
shaking at 250 rpm in selective low salt LBzeocin (25 mg/L) media. 
 Aliquots of 500µl of overnight cultures for each cloning strategy were saved in 50% 
glycerol (final concentration) at -80
o
C. For cloning strategy 1, designed such that PGT 9 would 
not be secreted into the media, four colonies labeled PX 18 S. C. 6 (X6) and 7 (X7)  (Positive X 
Colony 18 single colonies 6  and 7), PX 23 S. C. 15 (X15), and PX 18 S. C. 9 (X9) were saved. 
For strategy 2, designed such that PGT 9 would be secreted into the media with 14 extra amino 
acids at the N-terminal, PY A, B, C, and D (Positive Colony Y single colonies A, B, and D) were 
saved. For Strategy 3, designed such that PGT 9 is secreted into the media with a native N-
terminal, PZ 1, 4, 9, and 17 (Positive Colony Z single colonies 1, 4, 9, and 17) were saved. 
In order to confirm presence of PGT 9 in pPICZA and pPICZAα vectors, 5ml of each 
overnight culture was used to carry out minipreps to isolate the vectors containing the PGT 9 
insert. The recombinant vectors were digested with corresponding restriction enzymes to confirm 
the presence of the modified PGT 9 inserts in the pPCIZA and pPICZAα vectors. For digestion 
of 5µl of the PX S. C. miniprep samples (strategy 1), 1µl of Kpn I (10µg/µl) and 1µl of Apa I 
(10µg/µl) restriction enzymes, 2μl of dH2O and 1µl of 10 X promega buffer A were mixed and 
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incubated at 37
o
C for 4 hours. Aliquots of 5µl of PY and PZ miniprep samples were also 
digested. For PY, 1µl of Kpn I (10µg/µl) and 1µl of Xba I (10µg/µl) was used while for the PZ 
samples, 1µl of Xho I (10µg/µl) and 1µl of Xba I (10µg/µl) was used. To ensure complete 
digestion, 1µl of each enzyme was added to each digestion reaction after 2 hours and then 
incubated again for another 2 hours. Digestion reactions were terminated by incubation of the 
reactions at 65
o
C for 5minutes. The digested samples were then analyzed on a 0.8% agarose gel 
containing EtBr as previously described to confirm presence of PGT 9 inserts in the pPICZA and 
pPICZAα vectors and if they corresponded to the right sizes. A 30µl aliquot of each of the 4 PX 
samples was sent for DNA sequencing as were PY A and C samples and PZ 1 and 9 samples. 
Samples were sequenced at University of Tennessee, Knoxville Sequencing Facility. P.X 8 S. C 
6 (X6), PY A, and PZ 1 were selected for transformation into yeast.  
 
Transformation of Recombinant PGT 9 and Empty Vectors into Pichia pastoris 
Plasmid Midiprep of pPICZA, pPICZAα, and Recombinant Vectors Containing PGT 9 
For transformation into yeast, 5-10µg of DNA is required in a maximum volume of 10µl 
according to the Easy select Pichia manual (Invitrogen). Selected positive colonies were grown 
overnight in 50ml of selective low salt LBzeocin (25mg/L) media at 37
o
C while shaking at 250 rpm. A 
midiprep was carried out using 40ml of the overnight culture using the Quantum Prep Plasmid 
Midiprep Kit according to manufacturer’s instructions except that 30s spins were extended to 60s 
to ensure complete elution. Elution was performed using 600µl of sterile dH2O. A 2µl and 5µl 
aliquot of each midiprep was analyzed on a 0.8% get containing EtBr as previously described. 
Samples were run alongside quantitative DNA markers as previously described. The intensities 
67 
 
of the midiprep bands were compared with that of the intensities of the bands of the 1kb plus 
exACTGene DNA ladder to determine the concentration of DNA in each sample (Table 9). 
 
Table 9. DNA Concentration from Quantified Midipreps of Recombinant PGT 9 and Vectors 
     Vector                              µg/600µl     PGT 9 Insert                     (µg/600µl) 
    pPICZA                          16.89                      X6                18.0 
    pPICZAα                          10.8           Y2                           14.4 
                                                                      Z13                                   12.3 
 
Linearization, Purification, and Concentration of Plasmid DNA 
A 300µl aliquot of each plasmid was linearized using Sac I. The Sac I restriction enzyme 
cuts once in the 5’ AOX 1 region of the vector  to linearize the empty and recombinant vectors  
prior to transformation into yeast. Sac I was selected based on the restriction mapping of PGT 9 
that confirmed there are no internal Sac I sites within the PGT 9 sequence.  Each digestion 
reaction consisted of 300µl of midiprep, 30.3µl of buffer J, and 3µl of Sac I. The digestion 
reaction was incubated at 37
o
C for 2 hours after which an additional 3µl of Sac I was added and 
incubated for another 2 hours to ensure complete digestion. Digestion was terminated by 
incubating the digestion reaction at 65
o
C for 5 minutes. A 2µl aliquot was analyzed on a 0.8% 
agarose gel containing EtBr to confirm complete linearization of each construct. 
Phenol: chloroform extraction and ethanol precipitation were performed to get the 
required concentration of DNA and also to get rid of contaminating proteins in the sample. 
Phenol:chloroform was prepared in a ratio of 1:1 as described in the appendix and stored at 4
o
C. 
An equal volume (320µl) of the phenol: chloroform was added to each of the linearized plasmid 
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samples and vortexed for 10s. It was then centrifuged for 60s at 10,000 X g in microcentrifuge at 
room temperature. The top (aqueous) phase was collected and transferred to a new 
microcentrifuge tube and an equal volume of chloroform added. It was vortexed again and 
centrifuged for 1minute and the top (aqueous) phase was collected and transferred into a new 
tube. After the phenol:chloroform extraction, ethanol precipitation of DNA was carried out. First, 
1/4 volume of 7.5M ammonium acetate was added to the aqueous phase and then 2 volumes of 
ice cold 100% ethanol was added, the sample gently mixed and incubated at -80
o
C for 15 
minutes. The sample was centrifuged at 10,000 X g for 15 minutes at 4
o
C. The ethanol was 
removed and the DNA resuspended in 250µl of ice cold 80% ethanol. The sample was 
centrifuged again at 10,000 X g at 4
o
C for 10 minutes. The orientation of the tube in the 
centrifuge was noted in order to keep track of the DNA pellet. The ethanol was decanted gently, 
the DNA pellet dried in a speed vac, and the pellet resuspended in 10µl of sterile dH2O.  
In order to determine the concentration of DNA, a 1:100 dilution using 0.5µl of each 
concentrated DNA sample was carried out. A 2µl and a 5µl aliquot were analyzed alongside 
quantitative markers on a 0.8% agarose gel as previously described. This also helped to confirm 
the sizes of the empty vectors and the vectors containing the PGT 9 inserts. When desired 
concentrations of 5-10ug/5-10ul of water were not achieved, more plasmid DNA was linearized, 
purified (phenol:chloroform), and concentrated (ethanol precipitation). The sample that did not 
have the required DNA concentration for transformation was used to resuspend the newly 
concentrated sample to raise the concentration of the DNA sample. 
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Transformation into Pichia pastoris by Electroporation 
Competent yeast cells were prepared for this process. The Pichia pastoris strain X33 was 
grown overnight in YPD medium (see appendix) at 30
o
C, 250rpm. A 0.5ml aliquot of the 
overnight culture was used to inoculate 500ml of freshly prepared YPD medium. The cells were 
grown overnight at 30
o
C to reach an OD600 of 1.309. The culture was centrifuged 4
o
C for 5 
minutes in a Sorvall RC-5B refrigerated super speed centrifuge (Fisher Scientific) at 1500 X g. 
The supernatant was discarded and the cells resuspended in 500ml of ice cold sterile water and 
centrifuged again to pellet the cells. This was followed by resuspending the cells in 250ml of ice 
cold water, centrifuged and the supernatant discarded. The pellet obtained from the previous step 
was resuspended in 20ml of ice cold 1M sorbitol and centrifuged.  The pellet obtained was 
resuspended in 1ml of 1M sorbitol to get a final total volume of 1.5ml. The competent cells were 
saved on ice and used on the same day. 
For the electroporation procedure, 0.2cm cuvettes were used as recommended by the 
Easy Select
TM
 Pichia manual (Invitrogen). A total of 5 cuvettes were incubated on ice, 3 of them 
to transform the different linearized vectors with the PGT 9 sequence and the two others for 
transforming empty vectors pPICZA and pPICZAα to serve as negative controls for subsequent 
rPGT 9 expression. For each transformation, a total of 8µg of DNA was used as shown in Table 
10. 
 
 
 
 
 
70 
 
Table 10. DNA Concentration from Phenol:choroform Extraction and Ethanol Precipitation 
Construct/Vector    Concentration (µg/µl)           Volume (µl) Used  Total DNA (µg)   
                       for Electroporation 
  X6         1.1    7.3                   8µg 
  PY A         1.55   5.2       8µg 
  PZ1         1.55   5.2       8µg 
  pPICZA            1.15                         7.0                       8µg 
  pPICZAα                                   1.3                                       6.2                               8µg 
 
 For each sample, 8µg of linearized DNA was mixed with 80µl of freshly prepared 
competent cells and transferred to the cold 0.2cm micropulser cuvette. This was incubated on ice 
for 5 minutes and then pulsed using a current of 1.5kV. Following the pulse, 1ml of ice cold 1M 
sorbitol was added to the cells and the mixture transferred into a sterile 15ml tube. The cells were 
then incubated at 30
o
C for 2hours without shaking for the cells to recover. Once cells had 
recovered, 25µl, 50µl, 100µl, and 200µl aliquots were evenly spread on selective low salt 
YPDSzeocin (50mg/l) plates (appendix). Competent cells acquire zeocin resistance as the vector 
contains the zeocin resistance gene. A negative control was done by transforming competent 
yeast cells with water and no vector. The plates were incubated at 30
o
C until colonies grew, 
which was on the 4
th
 day. The plates with colonies were stored at 4
o
C and PCR screens were 
carried out to confirm that the transformation process was successful. 
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PCR Screening of Pichia Transformants 
To confirm the insertion of PGT 9 constructs and vectors into the yeast genome, 17 
colonies were selected at random for each strategy and PCR screened using clone-specific 
primers. The PCR screens were carried out as previously described but with some modifications. 
Using a sterile toothpick, colonies were selected and inoculated in 5µl of sterile dH2O in 
a 1.5ml centrifuge tube. After inoculation, the sterile toothpicks were used to streak another 
YPDSzeocin (50mg/l) plate to save replicates. Yeast cells were not lysed by boiling as was the case 
with the E.coli cells. To lyse the yeast cells, a 1.5µl aliquot of 6U/µl solution of lyticase was 
added to the resuspended yeast cells and incubated in a 30
o
C water bath for 10 minutes. The 
samples were then frozen at -80
o
C for 10 minutes. A 1µl aliquot of each sample was used as 
template in the PCR screens. A master mix was prepared as previously described and 9µl of the 
mix was placed into 18 different PCR tubes. For each tube, 1µl of the template was then added. 
One tube received 1µl of water to serve as a negative control. The PCR cycles used was as 
previously described (Table 3). PCR reactions were analyzed on a 0.8% agarose get stained with 
ethidium bromide as previously described. 
Positive colonies were T-streaked on YPDSzeocin (50mg/l) plates to get single colonies that 
were then grown overnight in YPDSzeocin (50mg/l) medium and 500µl of culture was saved at -80
o
C 
in 50% glycerol. Five colonies were grown and saved for each cloning strategy as follows: for 
PGT 9 in pPICZA the samples were labeled X6[1] - X6[5] and their duplicates labeled X6[1]
 o
- 
[5]
 o
; for PGT 9 in pPICZAα to be expressed and secreted with 14 extra amino acids the samples 
were labeled PY A[1]- PY A[5] and their duplicates labeled PY A[1]
 o
- [5]
 o
; for PGT 9 in 
pPICZAα to be expressed and secreted with a native N-terminal the samples were labeled PZ 
[1]-[5] and their duplicates labeled PZ [1]
 o
- [5]
 o
; for yeast cells transformed with just the empty 
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pPICZA vector the samples were labeled pPICZA [1]-[5] and their duplicates pPICZA [1]
 o
-[5]
 o
; 
for yeast cells transformed with empty pPICZAα vector the samples were labeled pPICZAα [1]-
[5] and their duplicates pPICZAα [1] o-[5] o. 
 
Expression of Recombinant PGT 9 in Pichia pastoris 
Overnight culture from the glycerol stock of the positively transformed yeast cells for 
strategy 1 (PGT 9 in pPICZA) was carried out using the stock labeled X6[1]. A sterile toothpick 
was used to obtain a sample from the stock and inoculated in 250ml freshly prepared BMGY 
media (see appendix) and incubated at 30
o
C overnight at 250rpm to generate biomass for 
induction of rPGT 9. Biomass for yeast transformed with pPICZA (pPICZA [1]) vector was also 
generated to act as a negative control for the expression of rPGT 9. Once the culture reached an 
OD600 of 2.023 for X6 and 2.67 for the negative control (25hours), the cells were centrifuged in a 
Sorvall RC-5B refrigerated superspeed centrifuge at 3000 X g for 5 minutes at room temperature 
to pellet the cells. The cells were resuspended in BMMY media (see appendix) to an OD600 of 1.0 
and 1ml aliquots collected from both samples as preinduction samples were centrifuged at 
10,000 X g for 3 minutes and saved at -80
o
C in a 1.5ml microcentrifuge tube. The remaining 
sample was treated by adding 100% methanol to reach a final concentration of 0.5% to induce 
protein expression. For example, cells for expression of rPGT 9 (X6) were resuspended in a total 
volume of 125ml and 625µl of 100% methanol was added. The negative control cells were 
resuspended in a total volume of 250ml of BMMY and 1.25ml 100% methanol was used for 
induction. Each induction was carried out in a 1000ml baffled flask that was closed with a 
double layer of cheesecloth. The 1000ml flask containing the induced cells was incubated at 
30
o
C for 4 days while shaking at 250rpm. Samples (1ml) were collected every 6 hours for the 
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first 24 hours. Induction was maintained by adding 100% methanol to a final concentration of 
0.5% every 24 hours. After 24 hours, samples were then collected every 12 hours until the fourth 
day. Thus 1ml samples were collected at 6, 12, 18, 24, 36, 48, 60, 72, 84, and 96 hours 
postinduction. The 1ml samples were centrifuged at 10,000 X g and the cells stored at -80
0
C for 
subsequent analysis. 
 
Sample Preparation for Analysis 
The preindution and postinduction samples collected at the different time intervals were 
prepared for analysis by SDS PAGE and Western blotting. Cells were thawed and resuspended 
in 100µl of breaking buffer (50mM sodium phosphate, 1mM PMSF, 1mM EDTA, 5% glycerol, 
5mM pH 7.4). Cells were broken using acid washed beads. To the cells resuspended in 100µl of 
breaking buffer, an equal volume of 0.5mm acid washed beads was added. The sample was then 
vortexed for 30s, incubate on ice for 30s and the cycle was repeated 8 times. The samples were 
centrifuged at 4
o
C for 10 minutes at 10,000 X g. The supernatant, which should contain soluble 
rPGT 9, was transferred into a new 1.5ml microcentrifuge tube and kept on ice.  
 
SDS-PAGE and Western Blot Analysis of Samples 
A total of 50µl of each sample was used for this analysis. The 50µl samples were 
transferred into new microcentrifuge tubes and 50µl of 2X dye was added to the samples. The 
samples were incubated in a boiling water bath for 10 minutes and centrifuged at 10,000 X g for 
1 minute. Samples prepared consisted of both X6 transformed yeast cells and pPICZA 
transformed yeast cells (negative control). Samples were then analyzed by SDS PAGE as 
previously described with slight adjustments. From the prepared sample, 20µl was obtained and 
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run on the gel alongside 5µl of the broad range marker. Samples were run alongside the negative 
control samples corresponding to the times postinduction. Two gels were prepared: one gel was 
stained with coomassie blue stain to observe and see if there was expression of the rPGT 9 in the 
yeast cells transformed with the PGT 9 sequence against the negative control lanes, and one gel 
was used for Western blot analysis. 
Western blot analysis was carried out as previously described with slight adjustments. 
After transfer of proteins from the  gel to the nitrocellulose membrane, the membrane was 
blocked for 1 hour using blocking buffer prepared with 1X PBS (see appendix). Washes were 
carried out with 20ml of 1X PBST and antibodies were also prepared using 1X PBST. The 
primary antibody used was anti c-myc monoclonal antibody directed against the c-myc epitope at 
the C-terminal of rPGT 9. It was prepared by adding 2µl of antibody to 10ml of PBST (1:5000). 
Incubation with primary antibody was carried out at room temperature for 2 hours. Anti-goat 
antimouse IgG AP was used as secondary antibody diluted 1X PBST. A 1:10000 dilution (1µl of 
antibody in 10ml of 1X PBST) was used and incubation was for 1 hour. Development of 
nitrocellulose membrane for AP was done as previously described. 
 
Scale-Up of Expression, Desalting, and Enrichment of rPGT 9 
Based on the test inductions, 6 hours postinduction with methanol was chosen as the 
optimal time for sample collection. Cells were collected 6 hours postinduction, divide into 2 
samples and centrifuged at 3000xg for 5 minutes using the Sorvall RC-5B refrigerated super 
speed centrifuge at 25
o
C. The supernatant was discarded and the cell pellet was kept on ice. Cells 
were resuspended in 6ml of breaking buffer (50mM sodium phosphate, 1mM PMSF, 1mM 
EDTA, 5% glycerol, 5mM βME, pH 7.4).  
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Cells were lysed using French press (3 times at 2000psi) and centrifuged in a Sorvall RC-
5B refrigerated super speed centrifuge at 13000xg for 20 minutes at 4
o
C. The supernatant was 
collected and kept on ice and the pellet was discarded. 
A pre-packed PD-10 column was equilibrated with cold 25 ml of equilibration/wash 
buffer (50mM sodium phosphate, 300mM sodium chloride, 5mM BME, pH 7.5) at 4
o
C. The 
column was not allowed to run dry by capping it when there was about 2ml of equilibration wash 
buffer left at the top of the column. The remaining equilibration buffer was run out immediately 
before the sample was applied to the column. 
A total sample volume of 2.5ml was applied to the column and the first 2.5ml of flow-
through was collected and discarded. Wash buffer (50mM sodium phosphate, 300mM sodium 
chloride, 5mM BME, pH 7.5) was added to the column and the first 3.5ml of eluate was 
collected and saved on ice. The column was rinsed with 25ml of wash buffer (50mM sodium 
phosphate, 300mM sodium chloride, 5mM BME, pH 7.5) and then with 25ml of water. The 
column was saved at 4
o
C for future use. A total of 3.5ml desalted eluate sample was obtained 
from the PD-10 column. 
A 4 ml bed volume immobilized metal affinity column (IMAC) was used for rPGT 9 
enrichment. The packed column was equilibrated with 40 mls of equilibration buffer (50mM 
sodium phosphate, 300mM sodium chloride and 5mM BME, pH 7.5). The eluate sample from 
the desalting step was then run through the IMAC column adjusting the flow rate so that it took 
15 minutes (minimum) for the sample to pass through the column (approximately one drop every 
10s) to allow the rPGT 9 to bind to the column. Four fractions were collected and labeled flow-
through (FT 1-4). A 1ml sample was collected for the first 3 fractions and 500µl for the fourth 
fraction. The column was then washed with wash buffer (50mM sodium phosphate, 300mM 
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sodium chloride, and 5mM BME, pH 7.5), and 2ml fractions were collected while monitoring the 
A280  until it approached zero (12 fractions were collected and labeled EW 1-12). Tightly bound 
rPGT 9 was eluted with 150 mM imidazole buffer (150mM imidazole, 50mM sodium phosphate, 
300mM sodium chloride, 5mM BME, pH 7.5) and 2ml fractions were collected. A total of 10 
fractions were collected and labeled HF 1-10.  
Highly enriched 150mM fractions were collected and pooled together (fractions 1-4). The 
combined samples were transferred into a Centricon-30 and centrifuged in a Sorvall RC-5B 
super speed centrifuge using a swinging bucket at 4000 X g at 4
o
C until sample reached 500µl 
(sample was centrifuged for about 10 minutes). The sample was then resuspended in 2ml of 
50mM phosphate buffer containing 14mM βME (pH 7.5) and centrifuged at 4000 X g at 4oC for 
10 minutes. The sample was then resuspended in 2ml of 50mM phosphate buffer containing 
14mM βME (pH 7.5) and transferred into a 2ml microcentrifuge tube on ice to be used for 
screening for GT activity. A 400µl aliquot of the desalted and concentrated rPGT 9 was saved in 
20% glycerol (final concentration) at -20
o
C to test for the stability of the enzyme if activity was 
found. All fractions were analyzed by SDS-PAGE and Western blot after the enzyme assay had 
been carried out to confirm that the correct fractions (containing enriched rPGT 9) were used for 
the assay. 
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Screening Recombinant PGT 9 for Glucosyltransferase Activity 
Substrate and 
14
C-UDP Glucose Preparation 
The aglycone substrates to be tested were prepared to a stock concentration of 
50nmols/5µl in ethylene glycol monomethylether. The substrates used, their molecular weights, 
and amount used are listed in Table 11. Once each substrate was used, the remainder was tightly 
capped, sealed with parafilm, and stored at -20
o
C in a non-self-defrosting freezer. The molecular 
weight of each compound used is shown in Table 11. 
 
Calculation: 
50nmols x molecular weight of substrate = mass required/ 5µl of 100% ethylene glycol              
monomethylether. 
 
UDP-
14
C glucose was diluted to 20,000cpm/10µl in 50mM phosphate buffer of pH 7.5 
from a stock of 50µCi/2.5ml. A 0.451µl aliquot UDP-
14
C glucose stock was added to 9.55µl 
buffer to obtain 20,000cpm/10µl. 
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Table 11. Flavonoid Substrates Used for Recombinant PGT 9 Enzyme Assay and their Molecular 
weights. 
Class of flavonoid substrate Molecular 
Weight 
Chalcone 2’,4,4’,6’ tetrahydroxychalcone 272.25 
Flavanone Naringenin 272.25 
Hesperitin 302.2 
Eriodictyol 288.25 
Isosakuranetin 286.28 
Prunin (Naringenin 7-O-
glucoside) 
434.4 
Flavone Apigenin 270.25 
Luteolin 286.28 
Diosmetin 300.26 
Scutallerein 286.24 
Luteolin-7-O- glucoside 448.39 
Flavonols Kaempferol 286.24 
Quercetin 338.3 
Fisetin 286.24 
Gossypetin 318.14 
4’ methoxyflavonol 268.27 
Isoflavone 4’-acetoxy-7-hydroxy-6-methoxy 
isoflavone 
326.31 
Phenolics 
 (Coumarins) 
Umbelliferone 162.15 
Esculetin 178.15 
Simple Phenolics 2’,4’ dihydrobenzaldehyde 138.12 
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Glucosyltransferase Screening Assay for rPGT 9 
GT activity was screened adapting the method of McIntosh et al. (1990). For the enzyme 
reaction, 5µl containing 50nmoles substrate, 10µl of UDP-[U-
14
C] glucose (20,000cpm/10µl), 
10µl of concentrated rPGT 9 and 50µl of 50mM phosphate buffer (pH 7.5) containing 14mM 
βME were combined in a microcentrifuge tube to make a final reaction volume of 75µl. This was 
carried out in duplicates. Each reaction was incubated at 37
o
C for 15 minutes. Each reaction was 
terminated by adding 15µl 6M HCl. 
Two negative controls were carried out. One set was run without rPGT 9 and 1 with 
denatured rPGT 9. rPGT9 was denatured by boiling for 10 minutes in a water bath. The negative 
control with denatured rPGT 9 had 15µl of 6M HCl added before adding 10µl of rPGT 9 to the 
reaction. A positive control was carried out by using young grapefruit leaf extract as an enzyme 
source because young leaves have been shown to be a rich source of GT activity. The leaves 
were ground in 50mM phosphate buffer (pH 7) containing 14mM BME. A 50µl aliquot of the 
extract was added to 10µl of 50mM phosphate buffer, 10µl of UDP-[U-
14
C] glucose 
(20,000cpm/10µl) and 5µl of naringenin (50nmol/5µl). To test if the concentrated enzyme 
fraction from yeast had any inhibiting effects on the reaction, another positive control was 
carried out with grapefruit leaf extract and 10µl of rPGT 9 in place of the 50mM phosphate 
buffer. After stopping the reaction as previously described, 250ul of ethyl acetate was added and 
vortexed vigorously for 10 seconds. A 150ul aliquot of the organic phase (upper phase) was 
collected, 2ml of cytoscint scintillation fluid was added and the samples counted using a 
Beckman LS 6500 scintillation counter. As only 150µl of the ethyl acetate layer was counted, the 
formula below was used to calculate the total cpm of UDP-
14
C glucose incorporated in 250µl:  
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 Measured CPM/150µl = Xcpm /250µl to get the total CPM in 250µl.           
                                  
 For the water soluble simple phenolics, reverse-phase (RP) HPLC was used. The reaction 
was set up with 35µl of the concentrated rPGT 9, 20µl of cold UDP-glucose (100nmols), and 5µl 
of aglycone substrate (50nmols). The reactions were incubated in a 37
o
C water bath for 30 
minutes. The reaction was stopped by adding 200µl of methanol to the reaction. The samples 
were then centrifuged at 10,000 X g for 15 minutes to precipitate the proteins. The supernatant 
for each sample was transferred into a new tube and dried using a Speedvac concentrator from 
Thermo Electron Corporation (Waltham, MA). The pellets obtained were resuspended in 40µl of 
milli Q water and analyzed by C-18 RP HPLC with isocratic elution. Flow rate was 1ml/min. 
using Waters 1525 Binary HPLC Pump ,Waters 2487 Dual λ Absorbance Detector, and Waters 
Symmetry® C18 column (5μm, 4.6 × 150 mm) from Waters (Milford, MA). Elution strategy 
used for each substrate is shown in Table 12. The wavelengths used for detection correspond to 
the λmax of the aglycones. 
 
Cloning of PGT 11 into pPICZA for Transformation into Pichia pastoris 
Primer Design and Cloning Strategy 
 PGT 11 consensus sequence was also identified from the harvEST database and 
successfully amplified from a young grapefruit leaf cDNA library (Mallampalli, 2009). It was 
cloned into TOPO vector and transformed into E. coli (Mallampalli, 2009). In this current study, 
primers were designed to modify the ends of PGT 11 to introduce restriction sites present in the 
multiple cloning sites of pPICZA. Two primers were designed for this purpose. The sense primer 
was designed to introduce the yeast consensus sequence and the Kpn I restriction site. In order to 
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introduce the yeast consensus sequence, 2 amino acids would have to be added to the N-terminus 
of the rPGT 11 after it is expressed (Figure 16). 
 
Table12. Structures of Aglycones and HPLC Conditions Used for Analysis of Different Simple 
Phenolic Substrates (adapted from Ahmad and Hopkins 1993; Lin 2011 and ref. therein). 
 
Note. Mobile phases were diluted in 0.1M sodium phosphate buffer (pH 3.0). ACN: 
Acetonitrile. MeOH: Methanol. 
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Figure 16. Cloning Strategy for PGT 11 into pPICZA Vector. Recombinant PGT 11 will be 
expressed and secreted with 2 extra amino acids at the N-terminus (adapted from Invitrogen 
manual). 
 
 The antisense primer was designed to introduce the SacII restriction site and also to take 
off the stop codon of PGT 11 such that it would be recombinantly expressed with a c-myc 
epitope for detection and a polyhistidine tag (6X His tag) for purification. Primer designs are 
shown in Table 13. 
 
Table 13. Primers, Tm, and Restriction Sites Introduced for Cloning PGT 11 into pPICZA.  
Green=linkers, purple=restriction sites, red= original PGT 11 start codon, Blue= bases 
introduced to obtain the yeast consensus sequence [(G/A) NNATGG] as instructed by the user 
manual. NB. Blue sequence introduces a new start codon adding 2 amino acids to the N-terminal 
of PGT 11 when expressed. 
 
Sense primer Antisense primer 
 
 
(CSP138F) (50⁰C)(KpnI restriction site) 
5’ CGGGGTACCGCCATG GCCATGAGCAGTCCCCATGTTGTG 3’ 
 
 
 
(CSP139R)( 52⁰C)(SacII restriction site) 
5’ CCTCCGCGGTGCGGGCCATTGCTTG 3’ 
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Plasmid (PGT 11-TOPO) DNA Isolation  
In order to modify ends of PGT 11, Top 10 E. coli cell containing PGT 11 in pCR4 
TOPO were cultured in 10ml of LB amp(100mg/L) [Luria-Broth media containing ampicillin at 100 
milligrams/liter] overnight at 37
o
C, 250 rpm. The next morning, a plasmid miniprep was carried 
out following the QIAprep Spin Miniprep kit protocol. A total of 500ml of low salt LBzeo (25mg/l) 
(see Appendix B) was also prepared for culture of TOP 10 cells containing pPICZA. A 10ml 
aliquot of this media was inoculated with the TOP 10 E. coli cells and cultured overnight at 
37
o
C, 250rpm and plasmid miniprep was carried out the following morning. A 2μl aliquot of 
each miniprep sample was mixed with 3μl of water and 1μl of 6X dye. The sample was run on a 
0.8% agarose gel at 100V for 30 minutes to confirm successful isolation. 
 
PCR Modification of 5’ and 3’ Ends of PGT 11 
A stock concentration of 200μM for each primer was prepared by centrifuging the tubes 
containing the primers in an eppendorf centrifuge for 1minute at 10,000 X g and then adding the 
appropriate amount of sterile distilled water. A 20μM working solution (final volume of 50μl) 
was prepared by adding 5μl of stock solution to 45μl of sterile distilled water. The 200μM stock 
and 20μM working solutions of primers were stored at -20˚C. 
Isolated plasmid DNA (PGT 11-TOPO) was used as the template for PCR amplification 
using clone-specific primers as shown in Table 12. PCR tubes contained 2.5μl of 20μM solution 
of sense and antisense clone-specific primers (CSP), 2.5l of a 1:1000 diluted template, 1ul of Taq 
polymerase, 10μl of 5X colorless buffer and 3lμl of sterilized deionized water. PCR steps, 
temperatures, and cycles are shown in Table 14. A 2μl aliquot of PCR products were analyzed 
using a 0.8% DNA agarose gel stained with ethidium bromide. 
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Table 14. PCR Steps Used in the Modification of 5’ and 3’ ends of PGT 11. 
Step Temperature (
o
C) Time (seconds) # of Cycles 
Initiation 94 60 1 
Denaturation 94 30  
30 Annealing 50 30 
Elongation 72 120 
Final Elongation 72 300 1 
 
TOPO Cloning of PCR Modified PGT 11 
The rPGT 11 PCR product was cloned into pCR
®
4-TOPO vector using the TOPO TA 
Cloning Kit (Invitrogen) according to manufacturer’s instructions. The TOPO cloning reaction 
consisted of 4μl aliquot of modified PGT 11 PCR products, 1μl of salt solution, and 1μl of 
TOPO vector and the reaction was incubated for 30 minutes at room temperature. The TOPO 
cloning reaction was subsequently transformed into One-Shot Top 10 competent E. coli cells as 
follows: a 2μl aliquot of the TOPO cloning reaction was transferred into tube containing 50μl 
competent cells. The procedures for transformation were carried out following the 
manufacturer’s instructions (Invitrogen). 
For the positive ligation control, 1μl of pUC19 was added to 50μl of One-Shot competent 
cells. After transformation, 250μl; of S.O.C medium was added to each transformation reaction. 
The reactions were then incubated at 37ºC at 225 rpm for 1hour and 100μl of culture containing 
transformation reaction was spread onto each LBamp(100mg/L) plate. For the pUC19 control, the 
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transformation was diluted 1:10 into LBamp(100mg/L) liquid media and 100μl was spread on each 
LBamp(100mg/L) plate. Plates inoculated with the transformation samples were incubated overnight 
at 37°C. 
Individual colonies from the PGT 11-pCR4 TOPO transformed plates were carefully 
picked using sterile toothpicks and streaked onto plates containing LBamp(100mg/L) media to make 
replicates. Each toothpick was then placed into a sterile 0.5ml eppendorf tube containing 100μl 
of sterile distilled water. The samples were boiled for 5 minutes to lyse the cells and 1μl of cell 
lysate was added to 9μl of PCR master mix. The PCR master mix contained the following: 4μl of 
10mM dNTPs, 10μl of 20μM T3 sense primer, 10μl of 20μM T7 antisense primer, 40μl of 5 X 
green Go-Taq buffer, 94μl of sterile dH20, and 2μl of Taq polymerase. The conditions for the 
PCR reaction were as previously described. Sterile dH2O was used in place of cell lysate as a 
negative control. The PCR products were analyzed using a 0.8% DNA agarose gel stained with 
ethidium bromide. 
Three positive colonies from each plate were T-streaked on selective LBamp(100mg/L)  agar 
plates to obtain single colonies. Single colonies were selected from the streaks, inoculated in 
25ml of LBamp(100mg/L), and grown overnight at 37
o
C at 250 rpm. From the overnight culture, 
500μl was collected and added to 500μl of sterile glycerol and stocks were stored at -80°C. From 
the remaining culture, midipreps were carried out using the Quantum Prep Plasmid Midiprep Kit 
according to manufacturer’s instructions except that 30s centrifugations were carried out for 60s 
to ensure complete elution. Elution of DNA sample was carried out with 600µl of sterile dH2O. 
A midiprep for the pPICZA vector was carried out from TOP 10 competent E. coli cells that had 
been transformed with the vector and stored at -80
0
C. 
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Restriction Digest of Insert and Vector 
Digestion was also carried out using the Kpn I and Sac II restriction enzymes to confirm 
the presence of PGT 11 in the TOPO vector. A 2μl aliquot of each midiprep from sample 
positive colonies (1, 2, and 3) was digested. The digestion mix was made up of 2μl of plasmid, 
1μl of buffer A, 1μl of each restriction enzyme, and 5μl of distilled water. This was incubated at 
37°C for 2hours. Each digest was then analyzed on a 0.8% agaroase gel stained with ethidium 
bromide. A 2μl aliquot of the pPICZA vector was also digested using the same set of restriction 
enzymes. Once plasmids were confirmed to have the modified PGT 11, a 40μl aliquot of each 
sample was sent to be sequenced at University of Tennessee Knoxville Sequencing Facility. 
Sequencing results confirmed the presence of modified PGT 11 in TOPO vector. Colonies 1and 
2 were selected for further work on PGT 11. 
In order to carry out ligation reactions, larger scale restriction digest of the modified PGT 
11 sequences and pPICZA were carried out (Table 15). From the midipreps, 16μl aliquots of 
modified PGT 11 in TOPO and pPICZA vector were digested with Kpn I/ Sac II restriction 
enzymes to obtain sticky ends for ligation. After incubating the digestion mix at 37
o
C for 2hours, 
1μl of each enzyme was added to the reaction and incubated for another 2hours at 37oC. This 
was to ensure complete digestion of the inserts and vectors.   
 
Table 15. Restriction Digest Set-Up for Modified PGT 11 and pPICZA 
Insert/Vector 
(16μl of each) 
Restriction Enzymes 
(1μl of each) 
Buffer 
(2μl of each) 
Colonies 1 and 2 
(PGT 11-TOPO)  
Kpn I/Sac II A 
pPICZA Kpn I/Sac II A 
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The digested samples were then run on a 0.8% agarose gel stained with ethidium bromide 
as previously described. PGT 11 and pPICZA vector digested bands were cut out of the agarose 
gel and gel- purified following the Promega Wizard SV Gel and PCR clean-up system. From the 
gel-purified bands, 2μl and 5μl of each insert and vector were loaded on an agarose gel as 
previously described alongside quantitative Lambda/Hind III and 1kb plus exACTGene DNA 
markers to determine the concentration of each and also to confirm the size of the insert and 
vectors. The concentrations of each gel purified digest were determined and recorded in Table 
16. Colony 1 was selected for ligation reactions. 
 
Table 16. Concentration of Digested pPICZA and PGT 11 Used for Ligation as Determined 
Using Quantitative DNA Marker. 
 
Vector/ Insert Concentration (ng/μl) 
Colony 1 (PGT 11) 
Colony 2 (PGT 11) 
pPICZA 
18.0 
18.0 
16.5 
 
Ligation of PGT 11 with pPICZA 
After determining the concentration of the vectors and insert, ligation were carried out 
using different molar ratios (insert:vector) of 1:1 and 3:1. The ligation mix was incubated at 15
o
C 
for 4hours. The different volumes used for the different ratios are recorded in Table 17.   
The different volumes used in the ligation procedure were as previously described. A 
total of 100ng of vector was used (Promega catalog, Part# 9PIM180). The volume corresponding 
to this was calculated by simply dividing the required amount (100ng) by the concentration of 
the vector. 
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Table 17. Reaction Mixtures for Ligation of pPICZA Vector and PGT 11 Insert. 
Molar Ratio      Volume Volume  Volume           Volume       Volume          Total 
(Insert to    of insert of vector     of T4 DNA     of ligase of sterile         volume 
 Vector )    used (µl) used (µl)        ligase (µl)      buffer (µl) water (µl)    (µl) 
1:1    1.2    13.2      2.2      2     3.4                22 
3:1    3.7    13.2      2.2      2      0.9   22 
After the ligation reactions were incubated, 2µl of the ligation products were transformed 
into Top10 E. coli cells to serve as a holding cell line. The procedure for transformation was as 
previously described. After adding 2µl of the cloning product to the 50µl of Top10 cells, it was 
incubated on ice for 30 minutes. The cells were then heat shocked at 45
o
C for 30 seconds and 
incubated on ice again for 2 minutes. Plain low salt LB zeocin(25mg/l) was used instead of SOC 
media due to high salt concentration in the SOC media which could inhibit the antibiotic zeocin 
leading to false positives. Cells were resuspended in 250ml of plain low salt LB media and 
incubated at 37
o
C in a vertical position for 1 hour while shaking at 225 rpm for the cells to 
recover.  For the negative control, 1µl of pUC 19 was transformed into 50µl of Top10 cells and 
the heat shock process followed as described. After 1 hour of recovery, 100µl of the cells were 
evenly plated on pre-warmed LBzeocin (25mg/L) agar plates and incubated overnight at 37
o
C. A 1:10 
dilution for the cells transformed with pUC 19 was carried out and a 100µl aliquot was evenly 
plated on low salt LBzeocin (25 mg/L) to serve as the negative control. 
Single colonies were selected from the plate on which cells transformed with the 3:1 
ligated product were grown. Six colonies were selected and a miniprep carried out as previously 
described. Samples were labeled Colony A-F. The miniprep samples were sent to be sequenced 
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at University of Tennessee Knoxville Sequencing Facility to confirm the presence of PGT 11 in 
pPICZA. 
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CHAPTER 3 
RESULTS 
Optimization of Soluble Recombinant PGT 9 Expression in E.coli 
The expression of rPGT 9 in E. coli resulted in most of rPGT 9 being packed in inclusion 
bodies as an insoluble fraction (Mallampalli, 2009). Several conditions were varied such as 
media, temperature, and time of sample collection postinduction but insufficient soluble protein 
was obtained for GT activity screening (Figure 17). Osmotic stress has been shown to increase 
the amount of soluble protein expressed in E. coli for some proteins (Arakawa and Timasheff, 
1985; Oganesyan et al, 2006).  For example, betaine and sorbitol have been used as osmotic 
reagents to improve on the amount of soluble proteins produced (Blackwell and Horgan, 1991; 
Arakawa and Timasheff, 1985). These osmolytes were used in LB amp(100mg/L), chlr (34 mg/L) in an 
attempt to increase the amount of soluble rPGT 9. As a control, induction for the expression of 
rPGT 9 was also carried out in the absence of betaine and sorbitol. More soluble rPGT 9 was 
observed when induction was carried out with betaine and sorbitol (Figures 17-18). Therefore, 
subsequent inductions of rPGT 9 expression were carried out in the presence of betaine and 
sorbitol. However, most of the rPGT 9 was still trapped in inclusion bodies (Figure 17). 
The effect of temperature on soluble rPGT 9 expression in the presence of betaine and 
sorbitol was also investigated. The time of sample collection postinduction was also varied. 
Results showed using media containing betaine and sorbitol at 25
o
C to be the optimum condition 
for the expression of soluble rPGT 9 in the E. coli system (Figure 18). The optimum time for 
sample collection was 6 hours postinduction. Results obtained for different expression 
experiments were not consistent with respect to the amount of soluble rPGT 9. Under optimum 
expression conditions, most of the rPGT 9 was still found in inclusion bodies (Figure 18). 
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Figure 17. Western Blot Analysis of Samples Collected at Different Times Postinduction from E. 
coli. A. Induction in the absence of betaine and sorbitol. B. Induction in the presence of betaine 
and sorbitol. Both inductions were carried out at 25
0
C. NB. Blot had to be over-developed to see 
soluble rPGT 9 bands hence the background noise seen on the blot. Most of rPGT 9 protein was 
trapped in inclusion bodies. BR. Broad Range Marker. 
 
 
 
 
 
Figure 18. Variation of Temperature and Time of Sample Collection Postinduction in the 
Presence of Betaine and Sorbitol in E. coli. From analysis, optimum condition for expression of 
soluble rPGT 9 was 6 hours postinduction at 25
o
C in the presence of betaine and sorbitol. NB. 
Gels were over developed to see soluble rPGT 9 bands hence sufficient soluble rPGT 9 was not 
obtained. BR. Broad Range Marker. 
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Enrichment of Soluble Recombinant PGT 9 by IMAC 
The optimal expression conditions for expression of soluble rPGT 9 and a larger cell 
culture were used to obtain a larger sample of soluble protein for enrichment by immobilized 
metal affinity chromatography (IMAC). Column fractions were analyzed by silver stained SDS-
PAGE gels and by Western blot analysis (Figure 19). Results show that there was still 
insufficient soluble rPGT 9 obtained from this procedure to be able to screen for GT activity 
(Figure 19 B). There also were many contaminating bands in the fractions in which soluble rPGT 
9 was detected (Figure 19 A). 
 
 
Figure 19. Enrichment of Soluble rPGT 9 by Immobilized Metal Affinity Chromatography. A. 
Silver stained gel of fractions eluted with a 150mM (HF) imidazole buffer. T9-T10. Last two 
fractions eluted with 10mM (T) imidazole. B. Western blot analysis of HF fractions. Soluble 
rPGT 9 protein was detected in fraction HF3. 
 
Plasmid DNA Extraction and PCR Modification of PGT 9 
Because of issues with inclusion bodies when expressing rPGT 9 in E. coli, rPGT 9 was 
cloned into pPICZA and pPICZAα vectors for transformation and expression in yeast. For 
cloning of PGT 9 into pPICZA and pPICZAα vectors, unmodified PGT 9 in pCR®4-TOPO 
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vector was isolated from Top10 competent E. coli cells. PGT 9 was modified to have Kpn I/ 
ApaI restriction sites to be cloned into the pPICZA vector. PGT 9 also was modified to have Kpn 
I / Xba I sites to be cloned into pPICZAα vector and PGT 9 was modified to have Xho I/ Xba I 
sites for cloning into the pPICZAα vector using a different cloning strategy. The PCR modified 
PGT 9 products were analyzed on a 0.8% agarose gel and the modified PGT 9 PCR product 
corresponded to the expected size of 1470bp  (Figure 20). 
                      
Figure 20. Agarose Gel Analysis of Miniprep of Unmodified PGT 9 and Vectors and PCR 
Modified PGT 9. A. Miniprep of plasmid DNA (PGT 9 in TOPO vector), pPICZA and pPICZAα 
vectors. A 2µl aliquot of each sample was loaded alongside Lamba/Hind III marker. B. PCR 
modification of PGT 9 for cloning into pPICZA and pPICZAα vectors. 
 
The modified PGT 9 sequences were then cloned into pCR
®
4-TOPO vector for 
amplification and transformed into one-shot Top10 E. coli competent cells to serve as a holding 
cell line. Single colonies obtained from the selective LBamp(100mg/L) plates were screened by PCR 
reactions using the modified PGT 9 sequences as templates for the reaction as described in 
methods. PCR screens of single colonies selected from selective LBamp(100mg/L) plates for each 
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modification strategy showed positive bands for all colonies (Figure  21). The amplified bands 
corresponded to the ~1470bp band of PGT 9 sequence that was expected (Figure 21). The plate 
with cells transformed with PGT 9 with Kpn I and ApaI restriction sites was labeled X, that with 
PGT 9 with Kpn I and Xba I was labeled Y, and the last plate having cells transformed with PGT 
9 modified with Xho I and Xba I, was labeled Z. Only 7 colonies grew on plate Y and all were 
PCR screened. All colonies screened showed amplification of the PGT 9 gene. This suggests that 
ligation with TOPO vector and transformation into E. coli was successful. 
           
Figure 21. PCR Screen Results of E. coli cells Transformed with PGT 9 Modified to Have 
Different Restriction Sites. PGT 9 band of ~1470bp was amplified for all the different 
transformation. 
 
 
Restriction Digests, Ligations, and Transformations of rPGT 9 into Top 10 Competent E. coli 
In order to further confirm cloning of rPGT 9 into TOPO for subsequent cloning into 
pPICZA and pPICZAα vectors,  E.coli colonies with positive PCR screen results were grown 
overnight in LBamp(100mg/l) media and the plasmid DNA isolated as previously described. Colony 
X6 (PGT 9 modified to have Kpn I/Apa I restriction site) was selected to be cloned in pPICZA. 
Colony Y2 (PGT 9 modified to have Kpn I/Xba I restriction sites) was selected to be cloned in 
X Y Z 
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pPICZAα for extracellular secretion of rPGT 9 protein with a nonnative N-terminal (14 extra 
amino acids). Colony Z13 (PGT 9 modified to have Xho I/Xba I restriction sites) was selected to 
be cloned into pPICZAα for extracellular secretion of PGT 9 with a native N-terminal. Once the 
plasmid for each modified PGT 9 sequence was isolated, a restriction digestion reaction was set 
up as described in the materials and method section. Restriction enzymes with sites incorporated 
into PGT 9 were used in the reaction.  
Results show the ~1470bp band corresponded to the PGT 9 sequence and the larger 
bands of 3956bp corresponded to the linearized TOPO vector (Figure 22 A). The linearized 
pPICZA and pPICZAα band corresponded to sizes of the linearized vectors which are 3329bp 
and 3593bp respectively (Figure 22 B). A 2µl and 5µl aliquot of each gel purified sample was 
run on an agarose gel and the concentration determined using 1kb plus exACTGene DNA 
quantitative ladder and Lambda/ Hind III marker (Figure 23). Concentrations are in Table 5. 
 
Figure 22. Restriction Digest of PGT 9 in TOPO and Empty pPICZA and pPICZAα Vectors. A. 
Complete Restriction Digest of Modified PGT 9 Sequences from TOPO Vector. B. Complete 
restriction digests of pPICZA and pPICZAα vectors for ligation with the corresponding digested 
PGT 9 sequences. Restriction enzymes used for each digestion are indicated. 
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Figure 23. Digested and Gel Purified PGT 9, pPICZA and pPICZAα Vectors. Concentrations of 
each sample were determined by comparing the band intensities with that of the quantitative 
markers. 
 
 
After determining the concentration of each sample, ligation was carried out at 15
o
C for 4 
hours. The ligated products were then transformed into One Shot Top 10 E. coli cells. Successful 
ligation was confirmed first by PCR reaction using CSPs that were used for each modification. 
Bands corresponding to PGT 9 were observed for each cloning strategy (Figure 24). Miniprep 
was also carried out and the isolated plasmid digested with the corresponding pair of restriction 
enzymes. After digestion, the ~1470bp band was observed (Figure 25). Band sizes of 3,329bp 
and 3,593bp corresponding to pPICZA and pPICZAα, respectively, were also observed on the 
gel (Figure 25). 
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Figure 24. PCR Screen Results of Selected E.coli Colonies Transformed with Modified PGT 9 in 
pPICZA and pPICZAα Vectors. Clone specific primers used for each modification were used in 
the PCR screens. Ligation into pPICZA and pPICZAα as well as transformation into E. coli were 
successful. 
 
 
Figure 25. Digestion of Plasmid DNA Isolated from Positive PCR Screened Single E. coli 
Colonies for Each Modification Strategy. Results confirm the presence of PGT 9 in each vector. 
Bands resulting from digestion corresponded to pPICZA (3329bp), pPICZAα (3593bp) and PGT 
9 (~1470bp). 
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Sequencing results confirmed the presence of PGT 9 sequence in both vectors in-frame 
with the c-myc epitope (for detection) and the 6X His tag (for purification).  X6, PY A, and PZ1 
were selected as colonies to be used for further work. Representative sequence alignments with 
original PGT 9 sequence for all three cloning strategies are shown in Figures 26-28. 
 
Linearization, Purification, Concentration, and Transformation of rPGT 9 into Pichia pastoris 
For transformation into yeast, 5-10µg of linearized DNA plasmid in 5-10µl of sterile 
deionized water was required. The pPICZA and pPICZAα vectors that contained the PGT 9 
sequences were linearized using Sac I as described in the materials and methods section. 
Complete linearization was confirmed as previously described. Band sizes corresponded to the 
size of rPGT 9 as well as to the empty vectors (Figure 29). rPGT 9 from strategy 1 (PGT 9 in 
pPICZA) has an expected size of ~4799bp while rPGT 9 from strategies 2 and 3 (PGT 9 in 
pPICZAα vector) had expected sizes of ~5062bp. Once complete linearization was confirmed, 
the rest of the digest was treated with phenol: chloroform extraction and ethanol precipitation to 
remove contamination proteins and concentrate the sample as described in the materials and 
methods. Each sample was run on an agarose gel to confirm that the sample had been 
concentrated (Figure 29).  
A 2µl and 5µl aliquot of each 1:100 diluted sample was run on the gel to determine the 
final concentration of DNA in the samples obtained after the phenol: chloroform extraction and 
ethanol precipitation (Figure 30). After the concentration was determined (Table 10), a volume 
corresponding to 8µg of DNA was used for the yeast transformation process. The transformed 
cells were then grown on selective YPDSzeocin (50mg/L) agar plates and single colonies were 
selected and PCR screened. 
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A 
             ....|....| ....|....| ....|....| ....|....| ....|....| 
                 10         20         30         40         50 
X6           GGAAACGACT TTTACGACAC TTGAGAAGAT CAAAAAACAA CTAATTATTC 
PGT 9         ---------- ---------- ---------- ---------- ---------- 
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....| 
                 60         70         80         90        100 
X6           GAAACGAGGA ATTCACGTGG CCCAGCCGGC CGTCTCGGAT CGGTACCATG 
PGT 9            ---------- ---------- ---------- ---------- -------ATG 
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....| 
                110        120        130        140        150 
X6           GATCCAGCCG GAGCAAGAAA AGTTCATGCA GTATGCGTTC CATATCCAGC 
PGT 9         GATCCAGCCG GAGCAAGAAA AGTTCATGCA GTATGCGTTC CATATCCAGC 
 
 
 
 
B 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     1410       1420       1430       1440       1450        
X6           TAATTTTGAC AGATTAGTTA AGATGGTTCT TCAGCAAGGA AATTGGACCG  
PGT 9     TAATTTTGAC AGATTAGTTA AGATGGTTCT TCAGCAAGGA AATTGGACCG  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     1460       1470       1480       1490       1500        
X6           GAACCGAAAC CCTTCACGGG CCCGAACAAA AACTCATCTC AGAAGAGGAT  
PGT 9     GAACCGAAAC CCTTCACTAG ---------- ---------- ----------  
 
 
             ....|....| ....|....| ....|....| ....|.... 
                     1510       1520       1530            
X6           CTGAATAGCG CCGTCGACCA TCATCATCAT CATCATTGA 
PGT 9        ---------- ---------- ---------- --------- 
 
Figure 26. DNA Sequencing Analysis of Recombinant PGT 9 (X6) in pPICZA with Original 
PGT 9 Sequence. A. 5’ sequence alignment of rPGT 9 with original PGT 9 sequence. B. 3’ 
sequence alignment. Red=PGT 9; Blue= restriction site; Purple= pPICZA. Green= 6X His tag. 
Orange=C-myc epitope. 
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A 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     310        320        330        340        350         
PY A                      CGAGAAAAGA GAGGCTGAAG CTGAATTCAC GTGGCCCAGC CGGCCGTCTC  
PGT9          ---------- ---------- ---------- ---------- ----------  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     360        370        380        390        400         
PY A         GGATCGGTAC CATGGATCCA GCCGGAGCAA GAAAAGTTCA TGCAGTATGC  
PGT9         ---------- -ATGGATCCA GCCGGAGCAA GAAAAGTTCA TGCAGTATGC  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     410        420        430        440        450         
PY A         GTTCCATATC CAGCACAAGG CCATGTAAGT CCCTTGATGC AAGTAGCCAA  
PGT9         GTTCCATATC CAGCACAAGG CCATGTAAGT CCCTTGATGC AAGTAGCCAA  
 
 
B 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     1410       1420       1430       1440       1450        
PY A          ACAATAATTT TGACAGATTA GTTAAGATGG TTCTTCAGCA AGGAAATTGG  
PGT 9        ACAATAATTT TGACAGATTA GTTAAGATGG TTCTTCAGCA AGGAAATTGG  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     1460       1470       1480       1490       1500        
PY A         ACCGGAACCG AAACCCTTCA CCGTCTAGAA CAAAAACTCA TCTCAGAAGA  
PGT 9        ACCGGAACCG AAACCCTTCA CTAG------ ---------- ----------  
 
 
             ....|....| ....|....| ....|....| ....|....| ... 
                     1510       1520       1530       1540     
PY A         GGATCTGAAT AGCGCCGTCG ACCATCATCA TCATCATCAT TGA 
PGT 9        ---------- ---------- ---------- ---------- --- 
 
Figure 27. DNA Sequencing Analysis of Recombinant PGT 9 (PY A) in pPICZAα with Original 
PGT 9 Sequence. A. 5’ sequence alignment of rPGT 9 (PY A) with original PGT 9 sequence. B. 
3’ sequence alignment. Red=PGT 9; Blue= restriction site; Purple= pPICZA. Green= 6X His tag. 
Orange=C-myc epitope. 
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A 
            ....|....| ....|....| ....|....| ....|....| ....|....|  
                    210        220        230        240        250         
PZ 1         CGATGTTGCT GTTTTGCCAT TTTCCAACAG CACAAATAAC GGGTTATTGT  
PGT 9        ---------- ---------- ---------- ---------- ----------  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                    260        270        280        290        300         
PZ 1          TTATAAATAC TACTATTGCC AGCATTGCTG CTAAAGAAGA AGGGGTATCT  
PGT 9        ---------- ---------- ---------- ---------- ----------  
 
 
            ....|....| ....|....| ....|....| ....|....| ....|....|  
                    310        320        330        340        350         
PZ 1          CTCGAGAAAA GAATGGATCC AGCCGGAGCA AGAAAAGTTC ATGCAGTATG  
PGT 9       ---------- --ATGGATCC AGCCGGAGCA AGAAAAGTTC ATGCAGTATG  
 
B 
            ....|....| ....|....| ....|....| ....|....| ....|....|  
                    1410       1420       1430       1440       1450        
PZ 1         TAATTTTGAC AGATTAGTTA AGATGGTTCT TCAGCAAGGA AATTGGACCG  
PGT 9        TAATTTTGAC AGATTAGTTA AGATGGTTCT TCAGCAAGGA AATTGGACCG  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     1460       1470       1480       1490       1500        
PZ 1         GAACCGAAAC CCTTCACCGT CTAGAACAAA AACTCATCTC AGAAGAGGAT  
PGT 9        GAACCGAAAC CCTTCACTAG ---------- ---------- ----------  
 
 
             ....|....| ....|....| ....|....| ....|.... 
                     1510       1520       1530          
PZ 1         CTGAATAGCG CCGTCGACCA TCATCATCAT CATCATTGA 
PGT 9        ---------- ---------- ---------- --------- 
 
              
Figure 28. DNA Sequencing Analysis of Recombinant PGT 9 (PZ 1) in pPICZAα with Original 
PGT 9 Sequence. A. 5’ sequence alignment of rPGT 9 (PZ 1) with original PGT 9 sequence. B. 
3’ sequence alignment. Red=PGT 9; Blue= restriction site; Purple= pPICZA. Green= 6X His tag. 
Orange=C-myc epitope. 
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Figure 29. Completely Linearized Empty Vectors and Vectors Containing PGT 9 Insert. 
Linearization was carried out using Sac I restriction enzyme. Linearized plasmid bands 
corresponded to empty vector sizes and sizes of vector containing PGT 9 insert for the different 
cloning strategies as expected. Bands confirm that DNA samples were successfully concentrated. 
 
 
Figure 30. Diluted DNA Samples (1:100) of Phenol:chloroform and Ethanol Precipitated 
samples Used to Determine Concentration. Band intensities of each sample were compared to 
that of the quantitative markers. 
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Some of the single colonies for each strategy were positive (Figure 31). This confirms 
transformation of PGT 9 into the yeast genome. Yeast cells were also transformed with empty 
pPICZA and pPICZAα vectors to serve as negative controls for expression of rPGT 9 (Figure 
31). 
 
 
Figure 31. PCR Screen of Single Yeast Colonies After Transformation and Selection on the Low 
Salt LBzeocin (50mg/L) Agar Plates. Yeast genome was used as template and PGT 9 band (~1470bp) 
was amplified.  
 
 
Expression of Recombinant PGT 9 in Pichia pastoris 
For test inductions of rPGT 9, the positive colony labeled X6[1] was selected. Cells were 
inoculated in BMGY to generate biomass for induction. The cells from the BMGY culture were 
then transferred into BMMY media for induction with methanol. Samples were collected every 6 
hours for the first 24 hours and then every 12 hours for the next 3days postinduction. The 
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negative control, which consisted of yeast cells transformed with the empty vector, was also 
treated. Because of the small volume of test induction cultures, cells collected at different times 
postinduction were lysed using beads and analyzed by SDS PAGE and Western blot using 
antibodies against the c-myc epitope of rPGT 9. rPGT 9 was detected for all the samples except 
for the negative controls (Figure 32). 
 
 
Figure 32. Representative Western Blot Analysis of Test Inductions for Recombinant PGT 9 in 
Pichia pastoris at 30
o
C Using Methanol. Samples were collected at different times post 
induction. Detection was carried out using anti c-myc antibodies. A. Yeast cells transformed with 
empty vector. X6. Yeast cells transformed with PGT 9 sequence. 
 
 
A protein microassay was performed on the samples that were analyzed by Western blot. 
This was done in order to determine the protein concentration of each sample. Based on the 
concentrations obtained for each sample (Table 18), and the Western blot analysis (Figure 32), 
the optimal time for sample collection was determined to be 6 hours postinduction.  
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Table 18. Concentration and Volumes of Samples Used in Western Blot Analysis for Test-
Induction of Recombinant PGT 9 in Yeast.  
 
 
Scale-Up and Enrichment of Recombinant PGT 9 
Induction of rPGT 9 expression in yeast was carried out and all the cells were collected at 
6 hours postinduction, lysed and IMAC carried out to enrich soluble rPGT 9. The fractions from 
the column were analyzed by silver stained SDS PAGE gels. rPGT 9 was detected in the first 
four 150mM eluted fractions (Figure 33 A). These enriched fractions were pooled, desalted, and 
concentrated to further enrich rPGT 9. Western blot results showed that enrichment of rPGT 9 
was achieved (Figure 33 B).  
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Figure 33. Analysis of Fractions Obtained from Immobilized Metal Affinity Chromatography. A. 
Silver stained gels of fractions obtained from IMAC column. First four 150mM (HF) imidazole 
fractions were pooled, desalted and concentrated. B. Western blot analysis of fractions from 
IMAC. Blot confirms the concentration of rPGT 9 from the first four HF fractions. LR, Low 
range marker; FT, Flow through samples; EW, Washes with wash buffer; T, 10mM imidazole 
washes; HF,  150mM imidazole washes; [rPGT 9], Pooled, desalted and concentrated fraction. 
 
Screening Recombinant PGT 9 for GT Activity 
The pooled and concentrated fraction from the enrichment step was used to screen for 
activity of rPGT 9 using different flavonoid substrates and some simple phenolic substrates. No 
activity was detected for rPGT 9 for the 18 flavonoid substrates used in the assay (Table 19). 
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Table 19. Results from Screening Recombinant PGT 9 for GT Activity. No significant GT 
activity detected for substrates used. 
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 A positive control for the reaction was carried out using crude protein extract from young 
grapefruit leaf (Table 20). Quercetin was used as the substrate in the positive control reaction. In 
one of the positive control reactions, 10µl of the concentrated rPGT 9 fraction was added to 
determine if the reaction would be inhibited compared to the positive control that did not have 
the concentrated fraction of rPGT9. There was incorporation of radioactive counts in both 
controls which indicate that there was no inhibitory effect of the concentrated rPGT 9 fraction. 
 
Table 20. Results Obtained from Positive Control Reactions Using Grapefruit Leaf Extract with 
and without the Enriched rPGT 9 Fraction. Quercetin was used as substrate for controls. 
Positive 
Control 
Enzyme Source(s) Average CPM (n=2) 
Incorporated 
A Grapefruit Leaf Extract only 1330 
B Grapefruit Leaf Extract + [rPGT 9] 
fraction 
1294 
 
Initial screens did not determine the substrate for rPGT 9. Other phenolic compounds 
found in grapefruit (Table 12) in glucosylated forms were also screened as potential substrates 
for rPGT 9 (Fieldman and Hanks 1965; Harborne 1983; Gardana et al. 2008). Because of their 
water soluble nature, HPLC was used for analysis (Table 12). The reactions were carried out in 
duplicates. The standard for each substrate was analyzed once and the retention time was noted 
(Table 21). The experimental samples were then analyzed and the retention time from the 
duplicates compared with that of the standards (Table 21). Representative HPLC chromatograms 
for rPGT 9 reactions are shown in Figure 34. Positive controls were carried out using grapefruit 
young leaf crude extract as enzyme source. One positive control contained concentrated rPGT 9 
fraction while the other had just grapefruit leaf crude extract. A negative control was carried out 
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using denature enzyme with one of the potential substrate. Formation of new peak(s) with shorter 
retention time(s) as well as decrease in the aglycone peak is indicative of activity. This was 
observed for catechol, p-hydroxyphenylacetic acid, vanillin, vanillic acid, and gentisic acid 
(Table 21 and Figure 34). 
Table 21. Summary of Retention Times of Major Peaks for Standards, Positive Control, Negative 
Control, and Experimental Groups for Each Substrate. 
 
Compound 
Retention Time 
(RT) of Standard 
(minutes) 
Retention Time (RT) of 
Experimental. 
MEAN±SD (minutes) 
Retention Time of New 
Peak(s) Formed 
MEAN±SD (minutes) 
Catechol 2.70 (1) 2.82 ± 0.05 (2)  i) 2.02 ± 0.05 (2) 
ii) 1.44 ± 0.06 (2) 
Caffeic acid 6.61 (1) n. d. 6.01 ± 0.07 (2) 
p-Coumaric acid 12.03 (1) 11.92 ± 0.07 (2)  n. d. 
O-Coumaric acid 26.14 (1)  26.59 ± 0.09 (2) n. d. 
Ferulic acid 12.684 (1) 12.83 ± 0.03(2) n. d. 
Gentisic acid 12.888 (1) 13.68 ± 0.06 (2) n. d. 
Vanillic acid 10.253 (1)  10.01 ± 0.17 (2) i) 1.70 ± 0.06 (2) 
ii) 9.07 ± 0.03 (2) 
Vanillin 17.60 (1) 17.21  ± 0.61 (2) i) 1.75 ± 0.003 (2) 
ii) 9.11 ± 0.007 (2) 
Scopoletin 9.90 (1) 9.91 ± 0.02 (2) n. d. 
p-Hydroxyphenylacetic 
acid 
16.43 (1) 16.06 ± 0.02 (2) i) 1.68 ± 0.04 (2) 
ii) 2.30 ± 0.03 (2) 
iii) 7.38 ± 0.02 (2) 
p-Hydroxyphenylpyruvic 
acid 
4.66 (1) 4.49 ± 0.002 (2) n. d. 
p-Hydroxybenzoic acid 13.74 (1) 13.62 ± 0.03 (2) i) 1.67 ± 0.06 (2) 
ii) 7.46  ± 0.01(2) 
p-Hydroxybenzoic acid 
(Negative control with 
Denatured Enzyme) 
13.74 (1) 13.57  ± 0.10 (2) i) 1.65 ± 0.09 (2) 
ii) 7.41 ± 0.03 (2)  
Quercetin (Positive 
control with Grapefruit 
leave extract only) 
26.77 (1) 28.47 ± 1.58 (2) Multiple peaks 
Quercetin (Positive 
control with grapefruit 
leaf extract + concentrated 
rPGT9 fraction) 
26.77 (1) 30.71 ± 0.03 (2) Multiple peaks 
n = number of injections. n.d. = none detected. 
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A1. Quercetin Standard.  
 
A2. Positive Control Reaction 1 Using Quercetin as Substrate (Grapefruit Leaf Extract only).  
 
A3. Positive Control Reaction 2 Using Quercetin as Substrate (Grapefruit leaf extract + rPGT 9). 
 
 
B1. p-Hydroxybenzoic Acid Standard. 
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B2. Negative Control Using Denatured Enzyme and  p-Hydroxybenzoic as Substrate. 
 
B3. p-Hydroxybenzoic Experimental. 
 
C1. Caffeic Acid Standard. 
 
C2. Caffeic Acid Experimental. 
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D1. Ferulic Acid Standard, 
 
D2. Ferulic Acid Experimental. 
 
E1.O-coumaric Standard 
 
E2. O-coumaric Experimental 
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F1. p-Coumaric Acid Standard 
 
F2. p-Coumaric Acid Experimental 
 
G1. Scopoletin Standard. 
 
G2. Scopoletin Experimental 
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H1. Vanillic Acid Standard 
 
H2. Vanillic Acid Experimental 
 
I1. Vanillin Standard. 
 
I2. Vanillin Experimental. 
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J1. p-hydroxyphenylpyruvic Acid Standard 
 
J2. p-hydroxyphenylpyruvic Acid Experimental 
 
K1. p-hydroxyphenylacetic Acid Standard 
 
K2. p-hydroxyphenylacetic Experimental 
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L1. Gentisic Acid Standard. 
 
 
L2. Gentisic Acid Experimental 
 
 
K1. Catechol Standard. 
 
 
K2. Catechol Experimental 
Figure 34. Representative HPLC Chromatograms for rPGT 9 Assays with 12 Phenolic 
Compounds. Reduction of substrate peak height in the experimental chromatograms or 
appearance of new peaks suggests formation of a product. 
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Cloning of PGT 11 into pPICZA for Transformation into Pichia pastoris 
Plasmid DNA (PGT 11-TOPO) Isolation and PCR Modification 
For cloning of PGT 11 in to pPICZA vectors, unmodified PGT 11 initially cloned into 
pCR
®
4-TOPO vector was isolated from Top10 competent E. coli cells. PGT 11 was modified to 
have Kpn I/ Sac II restriction sites to be cloned into the pPICZA vector. The PCR modified PGT 
11 product was analyzed on a 0.8% agarose gel alongside the unmodified PGT 11 sequence in 
TOPO vector. Modified PGT 11 sequence corresponded to the expected 1374bp (Figure 35). 
 
Figure 35. Agarose Gel Analysis of Miniprep of Unmodified PGT 9 in TOPO Vector and PCR 
Modified PGT 11. 
 
The modified PGT 11 sequence was cloned into pCR
®
4-TOPO vector for amplification 
and transformed into one-shot Top10 E. coli competent cells to serve as a holding cell line. PCR 
screens of single colonies selected from selective LBamp(100mg/L) plates for each modification 
strategy showed positive bands for all colonies and the amplified bands corresponded to the 
~1374bp band of PGT 11 sequence that was expected (Figure 36). This suggests that ligation 
with TOPO vector and transformation into E. coli was successful. 
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Figure 36. PCR Screen Results of E. coli Cells Transformed with PGT 11 Modified to Have Kpn 
I and Sac II Restriction Sites. PGT 11 band of ~1374bp was amplified from each sample. 
 
Colonies 1, 2, and 3 were selected and midiprep was carried out to isolate plasmid DNA.  
A midiprep of pPICZA vector from Top 10 competent E. coli cells was also carried out. A 2μl 
aliquot of each isolated plasmid was digested with Kpn I and Sac II restriction enzymes. After 
digestion, the ~1374bp band corresponding to PGT 11 and the larger bands of 3956bp 
corresponding to the linearized TOPO vector were observed (Figure 37). A band size of 
~3,329bp corresponding to the digested pPICZA vector was also observed (Figure 37). 
Sequencing results confirmed the presence of PGT 11 sequence in the TOPO vector for all 
samples. Colonies 1 and 2 were selected for further work. 
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Figure 37. Digestion of pPICZA and Plasmid DNA Isolated from Positive PCR Screened Single 
E. coli Colonies.  
 
 
Restriction Digests, Ligations, and Transformation of Recombinant PGT 11 into Top 10 E. coli 
A 16µl aliquot of each plasmid DNA (modified PGT 11 in TOPO and pPICZA) were 
digested with Kpn I/ Sac II restriction enzymes and run on a 0.8% agarose DNA gel (Figure 38 
A). A 2µl and 5µl aliquot of each gel purified sample was run on an agarose gel and the 
concentration determined using 1kb plus exACTGene DNA quantitative ladder and Lambda/ 
Hind III marker (Figure 38 B and Table 16).  After determining the concentration of each 
sample, ligation reactions were set up as described in the materials and methods section. 
Successful ligation was confirmed by sequencing the recombinant plasmid isolated from 6 
colonies (Colonies A-F). Sequencing results confirmed the presence of PGT 11 in pPICZA and a 
representative sequence alignment with original PGT 11 sequence is shown below in Figure 39. 
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Figure 38. Digested and Gel Purified PGT 11and pPICZA Vector. A. Restriction digests of 
pPICZA and colonies A and B plasmids. B. Gel purified pPICZA and PGT 11 for ligation. 
Concentrations of each sample were determined by comparing the band intensities with that of 
the quantitative markers. 
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A 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                      10         20         30         40         50              
D-pPICZA_5   GGGTACGACT TTTACGACAC TTGAGAAGAT CAAAAAACAA CTAATTATTC  
PGT 11       ---------- ---------- ---------- ---------- ----------  
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                      60         70         80         90        100             
D-pPICZA_5   GAAACGAGGA ATTCACGTGG CCCAGCCGGC CGTCTCGGAT CGGTACCGCC  
PGT 11       ---------- ---------- ---------- ---------- ----------  
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     110        120        130        140        150         
D-pPICZA_5   ATGGCCATGA GCAGTCCCCA TGTTGTGGTA ATACCGAATC CAGAACAAGG  
PGT 11       ------ATGA GCAGTCCCCA TGTTGTGGTA ATACCGAATC CAGAACAAGG 
 
 
 
B 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     1360       1370       1380       1390       1400        
D-pPICZA_3   TCCATCAAGC AATGGCCCGC ACCGCGGCGG CCGCCAGCTT GGGCCCGAAC  
PGT 11       TCCATCAAGC AATGGCCCGC ATGA------ ---------- ----------  
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     1410       1420       1430       1440       1450        
D-pPICZA_3   AAAAACTCAT CTCAGAAGAG GATCTGAATA GCGCCGTCGA CCATCATCAT  
PGT 11       ---------- ---------- ---------- ---------- ----------  
 
             ....|....| ....|....| ....|....| . 
                     1460       1470       1480        
D-pPICZA_3   CATCATCATT GA 
PGT 11       ---------- ---------- ---------- - 
 
Figure 39. DNA Sequencing Analysis of Recombinant PGT 11 with Original PGT 11 sequence. 
A. 5’ sequence alignment of rPGT 11 with original PGT 11 sequence. B. 3’ sequence alignment. 
Red=PGT 11; Blue= restriction site; Purple= pPICZA.Tan=introduced yeast consensus sequence. 
Green= 6X His tag. Orange=C-myc epitope. 
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CHAPTER 4 
DISCUSSION 
Plant secondary metabolites play several roles in plants and have also been shown to have 
positive impacts on human health (Zhao et al. 2005 and ref. therein; Martens et al. 2010 and ref. 
therein; Kennedy and Wightman 2011). Flavonoids are a class of plant secondary metabolites 
and constitutes the third largest class of secondary metabolites with the terpenoids and alkaloids 
occupying the first and second positions, respectively (Zwenger and Basu 2008 and ref. therein; 
Martens et al. 2010 and ref. therein). Flavonoids play vital roles such as pigmentation, 
antibacterial and antifungal agents, UV protection, allelopathy, flavor, feeding deterrents, and 
feeding attractants, pollen germination, plant-plant interactions, and plant-insect interactions 
amongst other roles in plants (Li et al. 1993; Miller et al. 1999; Iwashina 2003 and ref. therein; 
Bylka et al. 2004; Cushnie et al. 2005). Several studies have also shown flavonoids to play vital 
roles in human health such as coronary heart diseases, strokes, cancer, and wound healing 
amongst others (Cook and Sammons 1996 and ref. therein; Brusselmans et al. 2005, Sen et al. 
2002, Vaya et al. 2003; Shetty et al. 2007). The remarkable properties of this class of compounds 
have drawn significant attention and a lot of research work on these compounds is being carried 
out. 
Once flavonoids are synthesized in plants, they undergo several different modifications 
and one of the prominent modifications is glucosylation. Glucosylation of these compounds 
changes their chemical properties as well as their biological activities. Glucosylation has been 
shown to impact the stability and transport of these compounds (Fukuchi-Mizutani et al. 2003; 
Zhao and Dixon 2009). Flavonoids are also involved in plant pigmentation and glucosylation has 
been shown to be important for this property (Fukuchi-Mizutani et al. 2003). Glucosylation, in 
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part, has also been shown to have an impact on the taste properties of these compounds (Mansell 
and McIntosh 1990). As mentioned earlier, these compounds play several roles in plants and 
most of the active forms required to perform the functions are glucosides (Iwashina 2003 and ref. 
therein; Solovchenko and Schmitz-Eiberger 2003). Glucosylation is therefore a very important 
modification for this class of compounds. 
The glucosylation of flavonoids is catalyzed by glucosyltransferase (GT) enzymes. These 
enyzymes bind a UDP-activated glucose and transfer the glucose moiety to its substrate (Owens 
and McIntosh 2009). These enzymes are therefore very important as they catalyze the 
modification of some of these flavonoids to their biologically active forms. Naringin, a bitter 
tasting flavanone, is highly accumulated in leaf tissues of grapefruit and makes up to 40-70% dry 
weight of young leaves and fruits (Jourdan et al. 1985; McIntosh and Mansell 1990). Naringin is 
a diglycoside and one of the sugar moieties is glucose. The enzyme that catalyzes the 
glucosylation of naringenin to yield prunin in grapefruit has been identified and biochemically 
characterized (McIntosh and Mansell 1990; McIntosh et al. 1990). Prunin is eventually 
rhamnosylated on the glucose moiety to yield naringin (Bar-Peled et al. 1991).  Other subclasses 
of flavonoids such as flavones and flavonols are also accumulated in high levels in the glucoside 
form (McIntosh and Mansell 1990; Owens and McIntosh 2011 and ref. therein). A flavonol 3-O-
GT (GQ141630) clone from grapefruit was identified and biochemically characterized (Owens 
and McIntosh 2009). Other plant secondary metabolites and phenolics are also present in 
grapefruit as glucosides (Berhow et al. 1998, Fieldman and Hanks 1965). Due to the high 
accumulation of flavonoid and other plant secondary metabolite glucosides in grapefruit, it is 
likely to be a rich source of these diverse GT enzymes. 
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The homology between different flavonoid GT sequences outside the PSPG box is very 
low. For example, the PSPG box of PGT 1 had up to 60% identity when compared with some 
other GTs but this identity decreased when the entire sequences were compared (RoySarkar et al. 
2007). Also, results from aligning individual pairs of a total of 88 GT sequences from 
Arabidopsis thaliana showed substantial differences between these sequences some lower than 
30% (Li et al. 2001). This makes it difficult to predict the function of these enzymes based on 
their sequence alone. GTs with very low sequence identity (20%) were shown to catalyze the 
glucosylation of the same set of molecules (Osmani et al. 2008 and ref. therein). Two other GT 
enzymes from the same class showed different levels of substrate specificity, one having a 
narrow specifity while the other having broad acceptor specificity (Osmani et al. 2008 and ref. 
therein). It is therefore necessary to clone, express, and screen for GT activity against a variety of 
substrates from different classes. 
 After PGT 9 and PGT 11 were identified from the harvEST database as Cit. 1322.1 and 
Cit. 6237, primers were designed and the sequences were successfully amplified from young 
graprefruit leaf cDNA (Mallampalli 2009). The sequence amplified from the young grapefruit 
leaf cDNA (PGT 9) had a single base difference at position 1263 when compared to the 
consensus sequence that was obtained from the database (Cit. 1322.1) as shown in Figure 11.  
This single base, however, did not lead to any amino acid change. This strongly suggests that 
PGT 9 could be evolutionarily conserved within citrus as the harvEST database consists of 
expressed sequence tags from different Citrus species.  The PGT 9 sequence contained the PSPG 
box and was therefore hypothesized to be a plant secondary product glucosyltransferase. Based 
on previous biochemical characterizations of flavanone 7-O-GT and flavonol 3-O-GT (McIntosh 
and Mansell 1990; McIntosh et al. 1990; Owens and McIntosh 2009), the hypothesis that rPGT 9 
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is a flavonoid GT and is biochemically regulated was also tested. The same hypotheses were also 
tested for rPGT 11. To test these hypotheses, rPGT 9 and 11 were cloned into yeast for 
heterologous expression and biochemical characterization. 
 
Expression of rPGT 9 in E. coli 
 Heterologous expression of rPGT 9 was first carried out using the E. coli expression 
system. The E. coli expression system offers a lot of advantages over other eukaryotic expression 
systems such as simplicity, well known genetics, fast high-density cell cultivation, as well as 
being inexpensive (Sorenson and Mortensen 2005). The vector used was pCD1, a modified 
version of the pET vector that has a thrombin cleavage site where the tags can be cleaved off 
after expression of the recombinant protein (Owens and McIntosh 2011 and ref. therein). It was 
cloned such that rPTG9 was expressed with an N-terminal thioredoxin tag and polyHis tag. 
Initial attempts to express rPGT 9 in E. coli yielded very little soluble rPGT 9 while the most of 
it was packed in inclusion bodies (Mallampalli 2009). The reasons why rPGT 9 may be packed 
in inclusion bodies include: over-expression, misfolding, and because it is a foreign protein. 
Several attempts to increase the amount of rPGT 9 such as varying media, temperature, and time 
of sample collection post induction did not yield any fruitful results (Mallampalli 2009).  
 Another factor that has been shown to increase the amount of soluble protein expression 
in E. coli is osmotic stress (Arakawa and Timasheff 1985; Blackwell and Horgan 1991). 
Blackwell and Horgan (1991), on using sorbitol and glycine betaine, reported a dramatic increase 
in the amount of soluble protein as well as the disappearance of the protein from the insoluble 
fraction. This strategy was employed in order to attempt to increase the amount of soluble rPGT 
9 being expressed. Based on Western blot analysis of samples induced in the presence and 
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absence of osmotic stress, a slight increase in the amount of soluble rPGT 9 was observed 
(Figure 16). Expression in the presence of betaine and sorbitol while varying temperature and 
time of sample collection postinduction was carried out in an attempt to determine the optimum 
conditions that yielded the most soluble rPGT 9. As shown in Figure 17, 25
o
C was still the 
optimum temperature while 6 hours was best time for sample collection. Even though this was 
the case, the amount of soluble rPGT 9 observed while expressing rPGT 9 under the same 
conditions was not repeatable. In an attempt to increase the amount of soluble rPGT 9 that could 
be isolated, the total volume of the cell culture was increased to 1 liter and the sample was 
processed and IMAC performed. Despite this, enough rPGT 9 was not obtained to test for 
activity and there was a lot of contaminating proteins in the fraction that contained the rPGT 9 
protein (Figure 19).  
 Even though some other clones yielded sufficient soluble protein when expressed in 
E.coli to test for activity (Owens and McIntosh 2009; Lin 2011) this was not the case with rPGT 
9.  Significant effort was put into expressing rPGT 9 in E. coli because the rPGT 9 was expressed 
such that it had a thrombin cleavage site at which the N-terminal tags could be cleaved (Owens 
et al. 2008; Owens and McIntosh 2009). This would have permitted the testing of activity of 
rPGT 9 with and without the tags to determine if the tags affected the activity of the rPGT 9. Due 
to the unsuccessful expression of sufficient amounts of soluble rPGT 9 in E. coli, another 
expression system was used. 
 
Expression of rPGT 9 in Pichia pastoris 
 Being a eukaryotic protein, expressing rPGT 9 in a eukaryotic expression system offers 
more advantages than a prokaryotic system. Pichia pastoris, a yeast strain, was selected as the 
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eukaryotic expression system. The advantages offered by using yeast for heterologous expression 
include: protein processing, folding and posttranslational modifications, higher protein 
production levels both intracellularly and extracellularly as well as the availability of the 
expression system as a commercially available kit (Cereghino and Cregg 1999; Invitrogen 
Manual Cat. No. K1740-01 2010 and ref. therein). PGT9 is a eukaryotic protein and may 
therefore fold better in an environment that is similar to its natural source than when expressed in 
a prokaryotic system. The major problem of inclusion bodies that was faced in E. coli is avoided 
by using a eukaryotic system and, as such, successfully expressed rPGT 9 will be found in the 
soluble fraction that can be used to test for activity. The Pichia expression system when 
compared to other eukaryotic systems is faster, easier, and less expensive (Invitrogen Manual 
Cat. No. K1740-01 2010).  Unlike the pCD1 vector, the pPICZ vectors have not been modified 
such that the tags can be cleaved off after recombinantly expressing PGT 9. It will not be 
possible to test the effect of the tags on the activity of rPGT 9 if activity is found.  One option 
would be to clone PGT 9 into the vectors with its stop codon before the tags, but this will result 
in losing the tags which are used to confirm expression and also enrich rPGT9. Another option 
would be to modify the vectors such that the protein is expressed with a cleavage site between 
rPGT 9 and its tags. As such the tags can be cleaved off. 
 pPICZA and pPICZAα were used as vectors for cloning rPTG 9 into Pichia. pPICZAα 
contains an α-secretory signal that drives the secretion of the expressed recombinant protein into 
the media. Expression of rPGT 9 in pPICZA does not lead to the secretion of rPGT 9 into the 
media and the cells have to be lysed to obtain the expressed protein. Both strategies were 
employed in cloning PGT 9 into Pichia. Successful cloning was confirmed by PCR using the 
yeast genome as a template and primers specific to rPGT 9 (Figure 31).  
128 
 
Secretion of rPGT 9 into the media serves as a purification step as Pichia secretes low 
levels of native proteins and as such, the major protein component of the media will be the 
secreted recombinant protein. Despite this apparent advantage, Pichia transformed with rPGT 9 
using pPICZA was used for expression over pPICZAα. The reason is that during the process of 
secreting the expressed recombinant protein from the Pichia cells, proteins with glycosylation 
site (Asn-X-Ser/Thr) get glycosylated (Invitrogen Manual Cat. No. K1740-01 2010). There were 
a couple of these sites found in the PGT 9 sequence and glycosylation would likely have a 
negative effect on the activity of the protein. The large volume of the media used to carry out 
induction is another obstacle as this needs to be concentrated before analysis. Given the low 
stability of flavonoid glucosyltransferases, secretion of the rPGT 9 in the media for up to 6 hours 
at 30
o
C could also lead to significant loss of activity before screening assays are performed. 
Despite this, an attempt was made to take advantage of the purification that is achieved after 
secretion of rPGT 9 into the media. 
rPGT 9 expression was induced with methanol. The rPGT 9 was cloned into pPICZA and 
pPICZAα to be under the control of the AOX1 promoter that is turned on in the presence of 
methanol. So, in the presence of methanol, the AOX1 promoter is turned on and the expression 
of rPGT 9 is driven. Successful expression was confirmed by Western blot analysis for rPGT 9 
cloned in pPICZA. rPGT 9 was not detected in the media and so the secretion strategies with 
pPICZAα did not work. 6 hours post induction was observed to be the best time for sample 
collection (Figure 32).  Immobilized metal affinity chromatography was used to enrich rPGT 9 
and the enriched fraction was used to test screen for GT activity (Figure 33). 
Due to the presence of the PSPG box, it was hypothesized that rPGT 9 was a plant 
secondary product glucosyltransferase, specifically a flavonoid GT. As such, some plant 
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secondary metabolites which are found in grapefruit were used to screen for GT activity (Berhow 
et al.1998; Fieldman and Hanks 1999; Owens and McIntosh 2011 and ref. therein). As 
glucosylated flavonoids are highly accumulated in Citrus paradisi, representative members of 
different classes of flavonoids were screened as the first potential substrates for rPGT 9. No 
significant activity was detected for the initial screens (Table 19). Therefore, results obtained 
with flavonoids do not support the hypothesis that PGT 9 codes for a flavonoid GT. 
A few potential simple phenolic substrates were also tested.  As shown in Figure 34, 
some of the simple phenolics did show new peaks for the experimental. This suggests that these 
compounds could be potential substrates for rPGT 9. There was reduction in the peak height of 
quercetin aglycone and appearance of several peaks in the experimental. Crude leaf extract was 
used and as such there are several enzymes present that could have used up quercetin to form 
multiple products. Also the presence of multiple peaks can be associated with the presence of 
other compounds in the crude extract. Because the quercetin aglycone was consumed 
significantly, it confirms that the assay conditions used were good. 
Based on the chromatogram of caffeic acid (Figure 34 C), the aglycone peak was not 
observed in the experimental and this suggests the complete conversion of the aglycone to 
product.  To observe how the caffeic acid aglycone is converted to product over time, then a time 
course reaction would be needed. For some of the substrates such as catechol, vanillin, vanillic 
acid, gentisic acid, p-hydroxyphenylacetic acid, and p-hydroxybenzoic acid, there was a slight 
reduction in the aglycone peak and/or the appearance of new peaks. The appearance of a new 
peak with a shorter retention time is indicative of the formation of a more polar compound which 
could be the glucoside. These compounds may be potential substrates for rPGT 9 protein. Some 
GTs are known to use several substrates and this could be the case for rPGT 9. A negative 
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control was carried out just for p-hydroxybenzoic acid and the new peaks observed in the 
experimental were also observed in the negative control sample (Figure 34 B). This may be 
because the enzyme was not completely denatured. The peak could also be as a result of some 
other component of the reaction. These experiments need to be repeated to confirm the results. 
The λmax used for the analyses were those of aglycones. If there is a considerable 
difference between the λmax of the aglycone and glucosides of these compounds, then it may not 
be possible to fully detect the glucoside peaks for the some of the compounds. It is for this 
reason that a reduction in peak height of the standard aglycone in the experimental is considered 
as an indication of activity. The use of several controls and possible the λmax of the aglycone 
and glucoside of these compounds will be necessary for interpretation. 
If the results with these simple phenolics are not reproducible, then the substrate of rPGT 
9 remains elusive. As such additional potential substrates found in grapefruit should be screened. 
There is also a possibility that rPGT 9 may have been denatured in the process of lysing the cells 
and during the process of enrichment even though similar methods were used for the biochemical 
characterization of rPGT 7 (GQ141630) (Owens and McIntosh 2009). Another possibility could 
be that PGT 9 uses a different sugar donor other than UDP-glucose. Even though most plant GTs 
use UDP-glucose as a sugar donor, there are other possible UDP-sugar donors such as UDP-
xylose, UDP-galactose, UDP-rhamnose, UDP-glucuronic acid and UDP-mannose (Osmani et al. 
2008). When a BLAST search was done using rPGT 9 protein sequence, it showed similarity to 
glucosyltransferases (data not shown) but, as mentioned earlier, function cannot be predicted by 
sequence alone and testing needs to be done. The C-terminal tag could also interfere with the 3-
D structure of the enzyme and, because there is no cleavage site to cut off the tag, the effect of 
the tag on the rPGT9 sequence will have to be tested at a later date.  
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Directions for Future Research 
The first logical step will be to retest the simple phenolic substrates that seemed to have 
products and/or a decrease in the peak of the aglycone. A time course experiment will confirm 
the conversion of substrate to product or simply the disappearance of the substrate that can be 
monitored by HPLC. This time course experiment is also necessary to determine the initial 
velocity of the reaction which is important for further characterization of rPGT 9. If one or all of 
these simple phenolics are substrates, then the kinetics of rPGT 9 can be studied in order to 
determine which of the substrates is the preferred substrate for rPGT 9. The optimum pH, buffer, 
and temperature will need to be determined before studying the kinetics of rPGT 9. 
 So far, not all the potential substrates found in grapefruit have been screened. If the 
simple phenolic experiments are not reproducible, the next logical step will be to continue 
screening for substrates until the PGT 9 activity is determined. Several other simple phenolics 
found in grapefruit that are not currently available in the lab such as sialicylic acid, phloretin, m-
coumaric among others should be acquired and tested (Fieldman and Hanks 1965). For example, 
there are other classes of plant secondary metabolites that have also been shown to exist in the 
glucosylated form such as terpenoids. Limonoate A-ring monolactone, a triterpenoid compound 
in grapefruit has also been shown to be glucosylated and would be a potential substrate to be 
tested (Hasegawa et al. 1997). The hypothesis that this is a plant secondary metabolite GT cannot 
be ruled out until other potential substrates are screened.  
The presence of the C-terminal tag could also affect the activity of PGT 9. The PSPG box 
that confers recognition and binding to the UDP activated sugar is situated near the C-terminal. 
There is a possibility that the tag could influence the 3-D structure of the rPGT 9 protein and 
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hence its ability to bind to the sugar donor or possibly the substrate as well. When PGT 7 
(GQ141630) was tested for activity with and without the N-terminal tags under optimal 
conditions (40
o
C, phosphate buffer, pH 7.5), there was little difference between the activities 
(Owens and McIntosh 2009) but when Tris HCl (pH 7.5) was used in place of phosphate buffer 
(pH 7.5), there was a 70% reduction in activity for the recombinant GQ121630 (McIntosh and 
Owens 2009). This shows that the the tag had an effect on the enzyme activity and this should be 
tested for rPGT 9. GQ141630 was expressed in E. coli with an N-terminal tag as opposed to a C-
terminal tag for rPGT 9. Therefore, the effect of the C-terminal tag on activity remains to be 
tested. Using a modified expression system that could result in the cleavage of the tags after 
expression of rPGT 9 could reveal the effect of the tag on the activity of the protein as screens 
can be carried out with and without the tag. The pPICZA vector should be modified to have a 
cleavage site such that when PGT 9 is expressed, the tags could be cleaved off. 
Also, as GQ141630 showed activity against flavonols, this clone will be heterologously 
expressed in yeast with a C-terminal tag and the activity compared with that expressed in E. coli 
with an N-terminal tag to compare the effect of both tags on GQ141630 activity (Devaiah and 
McIntosh Personal communication). If there is a significant decrease or total loss of GQ141630 
acitivity with C-terminal tags, then it is possible that the C-terminal tag could be interfering with 
the binding of the enzyme to the UDP-glucose since the UDP-glucose binding motif (PSPG box) 
for the enzyme is situated near the C-terminal. 
The reaction conditions used such as phosphate buffer of pH 7.5 as well as the 
temperature of 37
o
C are based on other experiments that have been conducted so far on other 
glucosyltransferases, most of which seemed to work best at these conditions (McItosh and 
Mansell 1990; McIntosh et al. 1990; Owens and McIntosh 2009). The optimum temperature for 
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flavonol 3-O-GT was 40
o
C (Owens and McIntosh 2009) while that if the flavanone 7-O-GT was 
37
o
C (McIntosh and Mansell 1990). Once activity of rPGT 9 is found, then the temperature and 
buffer pH would be varied to determine the optimal conditions required for its activity. 
PGT 11 is currently in the process of being transformed into Pichia. So far, PGT 11 has 
been successfully cloned into pPICZA vector. Once the desired linearized PGT 11-pPICZA 
construct is obtained from phenol: chloroform extraction, it should be transformed into Pichia. 
Optimization of expression and enrichment should be carried out as described for rPGT 9. The 
rPGT 11 protein should be screened for GT activity following the same procedures as described 
for rPGT 9 and for the flavonol 3-O-GT clone (Owens and McIntosh 2009). 
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APPENDICES 
APPENDIX A: Abreviations 
BME              - β-mercaptoethanol 
bp                   - base pairs 
BMGY           - buffered glycerol complex-medium 
BMMY           - buffered methanol-complex medium 
cDNA             - complementary deoxyribonucleotide acid 
CHI                - chalcone isomerase 
CHS               - chalcone synthase 
cpm                - counts per minute 
CSP                - clone specific primer 
DFR               - dihydroflavonol reductase 
DNA              - deoxyribonucleic acid 
dNTPs           - deoxyribnucleoside triphosphate 
EDTA            - ethylenediaminetetraacetic acid  
EtBR              - ethidium bromide  
EST               - expressed sequence tag 
F3GT             - flavonoid 3-O-glucosyltransferase 
F3H               - flavanone 3β-hydroxylase 
FLS               - flavonol synthase 
FSI                - flavone synthase I  
GT                 - glucosyltransferase  
IFS                 - isoflavone synthase 
LB                 - luria-bertani 
PAL               - phenylalanine ammonia lyase 
PBS               - phosphate buffered saline 
PCR               - polymerase chain reaction 
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rpm                - revolutions per minute 
SDS-PAGE   - sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
YPD              - yeast extract peptone dextrose 
YPDS            - yeast extract peptone dextrose with sorbitol 
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APPENDIX B: Stock Solutions and Media Recipes 
10X YNB: 
134 grams of yeast nitrogen base (YNB)  
Add 1000ml of distilled water 
Heat solution to dissolve completely 
Filter sterilize the solution and store at 4
o
C 
 
500X B (0.02% Biotin): 
20mg biotin 
Add 100ml dH2O 
Filter sterilize the solution and store at 4
o
C 
 
10X D (20% Dextrose): 
200 grams D-glucose  
Add 1000ml dH2O 
Filter sterilize and store at room temperature 
 
10X M (5 % Methanol): 
5ml methanol 
Add 95ml dH2O 
Filter sterilize and store at 4
o
C 
 
10X GY (10 % Glycerol): 
100ml glycerol 
Add 900ml dH2O 
Filter sterilize and store at room temperature 
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Plain Liquid LB Medium: 
25 grams LB broth powder 
Dissolve in 900ml of dH2O 
Adjust pH to 7.5 
Make up volume to 1000ml  
Autoclave and store at 4
o
C 
 
Liquid LB Medium with Antibiotics 
25 grams LB broth powder 
Dissolve in 900ml of dH2O 
Adjust pH to 7.5 
Make volume up to 1000mL  
Autoclave for 20minutes and allow to cool to about 55
o
C 
Add 0.1 gram of Amplicillin and/or without 0.034 gram of Chloramphenicol 
Store at 4
o
C 
 
LB-Agar Plate with Antibiotics:  
12.5grams of LB broth powder  
Add 900ml of dH2O 
Adjust pH to 7.5 
Add 7.5 grams of agar  
Make up volume to 1000ml  
Autoclave for 20minutes and allow to cool to about 55
o
C 
Add 0.1 gram Ampicillin and/or 0.034 gram Chloramphenicol  
Pour media into plates and allow to solidify 
Store at 4 
O
C. 
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Plain Liquid low Salt LB medium: 
10 grams tryptone 
5 grams yeast extract 
5 grams NaCl 
Dissolve in 900ml of dH2O 
Adjust pH to 7.5 
Add dH2O to 1000ml 
Autoclave for 20 minutes  
Store at 4
o
C 
 
Liquid Low Salt LB Medium with Antibiotics: 
10 grams tryptone 
5 grams yeast extract 
5 grams NaCl 
Dissolve in 1000ml of dH2O 
Autoclave for 20 minutes  
Allow to cool to about 55
o
C 
For low salt LB with Zeocin, add 25mg of zeocin 
Store at 4
o
C.  If media contains Zeocin store in the dark 
 
Low Salt LB Agar Plates: 
To a liter of plain low salt liquid LB media, add 15g agar 
Autoclave for 20 minutes 
Allow medium to cool to about 55
o
C  
Add desired antibiotics  
Pour into plates, allow medium to solidify 
Invert plates and store 4
o
C (If zeocin is added, store in the dark). 
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Plain liquid YPD medium: 
10 grams yeast extract  
20 grams peptone 
Add sterile dH2O to 900ml 
Autoclave for 20 minutes  
Add 100ml 10X  
 
Liquid YPD Medium with Zeocin: 
10 grams yeast extract  
20 grams peptone 
Add sterile dH2O to 900 ml  
Autoclave for 20 minutes  
Allow medium to cool to about 60 
o
C 
Add 100 ml 10X D 
Add 25 mg of Zeocin 
Store medium at 4
o
C in the dark 
 
YPD-Agar Plate with Zeocin: 
To a liter of plain YPD liquid medium 
Add 15 grams of agar 
Autoclave for 20 minutes 
Allow medium to cool to about 55
o
C 
Add 25 mg of Zeocin 
Pour medium in plates and allow to solidify 
Store plates containing zeocin in the dark at 4
o
C  
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 Liquid YPDS Medium with Zeocin: 
10 grams yeast extract 
182.2 grams sorbitol 
20 grams peptone 
Add sterile dH2O to 900ml  
Autoclave for 20 minutes  
Add 100ml 10X D 
Cool solution to ≈ 60oC 
Add 100 mg of Zeocin and store medium at 4
o
C in the dark 
 
YPDS-Agar plates with Zeocin: 
10 grams yeast extract 
182.2 grams sorbitol 
20 grams peptone  
15 grams of agar 
Add sterile dH2O to 900 ml  
Autoclave for 20 minutes  
Add 100 ml 10X D 
Cool solution to ≈ 60oC 
Add 100 mg of Zeocin and pour into plates. 
Store plates in the dark at 4
o
C 
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BMGY medium: 
10 grams yeast extract 
20 grams peptone 
Dissolve above in 700 ml distilled water 
Autoclave 20 minutes  
Cool to room temperature and add the following sterile solutions: 
100ml 1M potassium phosphate buffer, pH 6 
100ml 10X YNB 
2ml 500X B 
100ml 10X GY 
Store media at 4
o
C 
 
BMMY Medium: 
10 grams yeast extract 
20 grams peptone 
Dissolve above in 700ml distilled water 
Autoclave 20 minutes  
Cool to room temperature and add the following sterile solutions: 
100ml 1M potassium phosphate buffer, pH 6 
100ml 10X YNB 
2ml 500X B 
100ml 10X M 
Store media at 4
o
C  
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APPENDIX C: Staining Solution Recipes 
Ponceau S staining solution:  
0.5 grams Ponceau S  
10ml acetic acid  
Add dH2O to 100ml  
 
Amido Black Stain B:  
0.1 gram Amido Black 10B  
10ml acetic acid  
Add dH2O to 100ml 
 
Coomassie Blue Staining Solution: 
0.006 grams Coomassie Brilliant Blue G250  
10ml acetic acid  
40ml methanol  
Add ddH2O to 100ml 
 
Destaining Solution 
300ml Methanol (30%) 
100ml Acetic acid (10%) 
Make up volume to 1000ml with dH2O 
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APPENDIX D: Gel Recipes 
SDS-PAGE Gel (10 %) 
Separating Gel Composition: 
1.25ml 40% Acrylamide (acrylamide: bis-acrylamide, 19:1) 
1.25ml 4X running buffer 
2.33ml distilled water 
50µl 10% SDS 
50µl APS  
10µl TEMED (add last) 
 
Stacking Gel composition: 
200µl 40% Acrylamide (acrylamide: bis-acrylamide, 19:1) 
500µl 4X stacking gel buffer 
1.84ml distilled water 
20µl 10% SDS  
20µl APS 
5µl TEMED (add last) 
 
0.8/% Agarose Gel 
0.24 grams Agarose powder 
Add 30 ml of 1X TAE buffer 
Heat until agarose melts 
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APPENDIX E: Buffer Recipes 
4X SDS-PAGE Seperating Gel Buffer: 
36.5 grams (1.5 M) Tris-base  
Adjust pH to 8.8  
Add dH2O to 200ml 
 
4X SDS-PAGE Stacking Gel Buffer: 
3 grams (1.5 M) Tris-base pH 6.8  
Adjust pH to 8.8  
Add ddH2O to 200ml 
 
SDS-PAGE Running/ Tank Buffer: 
30 gramsTris Base 
144 grams Glycine 
10 grams SDS 
Add dH2O to 1000ml 
Adjust pH to 8.3 
 
10% SDS Solution: 
10 grams SDS 
Add ddH2O to 100ml 
 
2X SDS-PAGE Sample Buffer:  
25ml 1M Tris-base Buffer (pH 6.9)  
4 grams SDS  
20ml glycerol  
Add dH2O to 100ml (To every 1ml of the mixture, add 20μl βME before use). 
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4X SDS-PAGE Sample Buffer:  
2ml 1M Tris-base Buffer (pH 6.9)  
2ml 20% SDS Solution  
4ml 50% glycerol  
0.2mg Bromophenol Blue  
To every 1ml of above mixture, add 50μl βME before use  
 
10X TBS-T Buffer:  
8.76 grams sodium chloride  
10ml of 1M Tris-base solution pH 8.0 
500μl of tween-20 
Add ddH2O to 1000ml 
 
10X PBS Buffer: 
76 grams NaCl (1.3M) 
10 grams Na2HPO4 (70mM) 
4.1 grams NaH2PO4 (30mM) 
Adjust pH to 7.2 
Add ddH2O to 1000 ml 
 
1X PBS-T Buffer: 
100ml 10X PBS 
Add ddH2O to 1000ml 
Add 0.05 % of tween 20 and stir to mix completely 
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10X Western Blot Transfer Buffer: 
30 grams Tris base 
144 grams glycine 
Add dH2O to 1000 ml 
 
Alkaline Phosphatase Buffer: 
5.8 grams of NaCl 
1.02 grams of MgCl2 
100ml 1M Tris base solution 
Dissolve in 900ml of dH2O 
Adjust pH to 9.5 
Make up volume to 1000ml 
 
50mM Phosphate Buffer (pH 7.0): 
0.2918 grams of Monosodium Phosphate 
0.7733 grams of Disodium Phosphate 
Dissolve in 900ml of dH2O 
Adjust pH to 7 
Make up volume to 1000ml 
 
IMAC Equilibration/ Wash Buffer (pH 7.5): 
0.2918 grams of Monosodium Phosphate 
0.7733 grams of Disodium Phosphate 
17.532 grams of NaCl 
Dissolve in 900ml of dH2O 
Adjust pH to 7.5 
Make up volume to 1000ml 
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IMAC Elution Buffer (pH 7.5): 
0.2918 grams Monosodium Phosphate 
0.7733 grams Disodium Phosphate 
17.532 grams NaCl 
10.21g Imidazole 
Dissolve in 900ml of dH2O 
Adjust pH to 7.5 
Make up volume to 1000ml 
 
IMAC MES Buffer (pH 5.0): 
3.9046 grams 2-(N-morpholine)-methanesulfonic acid (MES) 
Adjust pH to 5.0 
Add dH2O to 1000ml 
 
50X TAE Buffer: 
50ml EDTA (pH 8.0) 
28.6ml Glacial Acetic Acid 
121 grams Tris Base 
Add ddH2O to 1000ml 
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Breaking Buffer: 
6 grams sodium phosphate (monobasic) 
372mg EDTA  
Dissolve in 850ml of dH2O 
Add 50ml glycerol 
Adjust pH to 7.4  
Add dH2O to 1000ml 
Store at 4
o
C  
To 57ml of the above mixture, add 10mg of PMSF right before use. 
 
1 M Potassium Phosphate Buffer, pH 6: 
132ml 1 M K2HPO4 
868ml 1M KHPO4 
Adjust pH to 6.0 
Autoclave for 20 minutes and store at room temperature 
 
Phenol Equilibration: 
Measure desired volume of phenol (25ml) 
Add 0.1% 8-hydroxyquinoline 2-carboxylic acid (25mg) 
Add equal volume (25ml) of 0.5M Tris-HCL (pH 8.0) 
Stir above mixture for 15 minutes 
Remove the upper-most layer of the mixture and discard 
Add an equal volume (25ml) of 0.1M Tris-HCl (pH 8) to the lower layer 
Stir for 15 minutes, measure pH using pH paper 
Repeat steps 3-7 until pH of phenol >7.8 
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APPENDIX F. Vector Maps 
pPICZA Vector Map (Adapted from Invitrogen Manual) 
 
 
 
pPICZAα Vector Map (Adapted from Invitrogen Manual) 
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